Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc.
1:09-cv-00184
Overview
Case Number
1:09-cv-00184
Filing Date
2009-03-19
Status
Terminated
Termination Date
2012-05-25
Court
District Court, D. Delaware (ded)
Presiding Judge
Leonard P. Stark
Nature of Suit
830 Patent
Jurisdiction Type
Federal Question
Cause of Action
35:271 Patent Infringement
Jury Demand
None
Parties
Defendant
Mylan Pharmaceuticals Inc.
Represented By
12 Attorneys ListedDoungamon Fon Muttamara-Walker
District of Columbia Office of
Tel: +1 (240) 447-9752
Administrative Hearings, 441 Fourth Street, N.W.
Potter Anderson & Corroon, LLP
Tel: +1 (302) 984-6000
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
Tel: +1 (302) 984-6000
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Plaintiff
Galderma Laboratories LP
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
Tel: +1 (302) 658-9200
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
Tel: +1 (302) 658-9200
1201 North Market Street, P.O. Box 1347
Galderma Laboratories Inc.
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
Tel: +1 (302) 658-9200
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
Tel: +1 (302) 658-9200
1201 North Market Street, P.O. Box 1347
New York University
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
Tel: +1 (302) 658-9200
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
Tel: +1 (302) 658-9200
1201 North Market Street, P.O. Box 1347
Research Foundation of State University of New York
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
Tel: +1 (302) 658-9200
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
Tel: +1 (302) 658-9200
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Leonard P. Stark
Docket Entries
COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)
2009-03-19
1
COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)
2009-03-19
2
COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)
2009-03-19
2
COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)
2009-03-19
2
COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)
2009-03-19
2
COMPLAINT filed against Mylan Pharmaceuticals Inc. -( Filing fee $ 350, receipt number 0311000000000564286.) - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(els) (Entered: 03/20/2009)
2009-03-19
2
Disclosure Statement pursuant to Rule 7.1 filed by Research Foundation of State University of New York. (els) (Entered: 03/20/2009)
2009-03-19
1
Disclosure Statement pursuant to Rule 7.1 filed by New York University. (els) (Entered: 03/20/2009)
2009-03-19
1
Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories Inc.. (els) (Entered: 03/20/2009)
2009-03-19
1
Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories LP identifying Other Affiliate Galderma General LLC, Other Affiliate Galderma Limited LLC for Galderma Laboratories LP. (els) (Entered: 03/20/2009)
2009-03-19
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (els) (Entered: 03/20/2009)
2009-03-19
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,232,572 B2; 7,211,267 B2; 5,789,395; 5,919,775; (els) (Entered: 03/20/2009)
2009-03-20
1
Summons Issued as to Mylan Pharmaceuticals Inc. on 3/20/2009. (els)
2009-03-20
1
No Actions
DECLARATION OF MAILING (as to Defendant Mylan Pharmaceuticals Inc.) by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Exhibit A & B)(Noreika, Maryellen) (Entered: 03/23/2009)
2009-03-23
1
Case assigned to Judge Joseph J. Farnan, Jr. Please include the initials of the Judge (JJF) after the case number on all documents filed. (rjb)
2009-03-25
1
No Actions
STIPULATION TO EXTEND TIME to answer, move against or otherwise respond to the Complaint to April 16, 2009 - filed by Mylan Pharmaceuticals Inc.. (Horwitz, Richard) (Entered: 04/09/2009)
2009-04-09
1
MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr. and Christine Willgoos - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Blumenfeld, Jack) (Entered: 04/13/2009)
2009-04-13
1
SO ORDERED, re 10 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr. and Christine Willgoos filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc.. Signed by Judge Joseph J. Farnan, Jr. on 4/14/2009. (nms)
2009-04-14
1
No Actions
SO ORDERED, re 9 STIPULATION TO EXTEND TIME to answer, move against or otherwise respond to the Complaint to April 16, 2009 filed by Mylan Pharmaceuticals Inc., Set/Reset Answer Deadlines: Mylan Pharmaceuticals Inc. answer due 4/16/2009.. Signed by Judge Joseph J. Farnan, Jr. on 4/14/2009. (nms)
2009-04-14
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Ron E. Shulman, Terry Kearney, and Roger J. Chin, of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Horwitz, Richard) Modified on 4/15/2009 (nms). (Entered: 04/15/2009)
2009-04-15
1
CORRECTING ENTRY: The docket text for D.I. 11 has been amended to reflect that the Motion request is for Roger J. Chin, Esq. as well. (nms)
2009-04-15
1
No Actions
MOTION to Dismiss Exceptional Case Claims - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order)(Muttamara-Walker, Doungamon) Modified on 5/28/2009 (nms). (Entered: 04/16/2009)
2009-04-16
1
OPENING BRIEF in Support re 12 MOTION to Dismiss for Failure to State a Claim [MYLAN'S MOTION TO DISMISS PLAINTIFFS' EXCEPTIONAL CASE CLAIMS] filed by Mylan Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 5/4/2009. (Muttamara-Walker, Doungamon) (Entered: 04/16/2009)
2009-04-16
1
ANSWER to 1 Complaint,, COUNTERCLAIM against all plaintiffs by Mylan Pharmaceuticals Inc..(Muttamara-Walker, Doungamon) (Entered: 04/16/2009)
2009-04-16
1
SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Ron E. Shulman, Terry Kearney, and Roger J. Chin of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc.. Signed by Judge Joseph J. Farnan, Jr. on 4/16/2009. (nms) Modified on 4/22/2009 (nms).
2009-04-16
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Blumenfeld, Jack) (Entered: 04/17/2009)
2009-04-17
1
SO ORDERED, re 15 MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc.. Signed by Judge Joseph J. Farnan, Jr. on 4/22/2009. (nms)
2009-04-22
1
No Actions
CORRECTING ENTRY: Roger J. Chin has been added to the docket text which So Ordered D.I. 11. (nms)
2009-04-22
1
No Actions
ORDER, Setting Hearings(A Scheduling Conference will be set for 5/27/2009 at 11:00 AM in Courtroom 4B before Judge Joseph J. Farnan, Jr.). Signed by Judge Joseph J. Farnan, Jr. on 4/23/2009. (Attachments: # 1 Form of Order)(nms) (Entered: 04/24/2009)
2009-04-23
1
ANSWERING BRIEF in Opposition re 12 MOTION to Dismiss for Failure to State a Claim filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP.Reply Brief due date per Local Rules is 5/14/2009. (Attachments: # 1 Exhibit A)(Blumenfeld, Jack) Modified on 5/5/2009 (nms). (Entered: 05/04/2009)
2009-05-04
1
ANSWER to 14 Answer to Complaint, Counterclaim by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP.(Blumenfeld, Jack) (Entered: 05/11/2009)
2009-05-11
1
REPLY BRIEF re 12 MOTION to Dismiss Exceptional Case Claims filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-B)(Moore, David) Modified on 5/15/2009 (nms). (Entered: 05/14/2009)
2009-05-14
1
PROPOSED ORDER (Rule 16 Scheduling Order) by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Letter to Judge Farnan enclosing Proposed Order)(Blumenfeld, Jack) (Entered: 05/22/2009)
2009-05-22
1
NOTICE OF SERVICE of Defendant's Rule 26(a)(1) Initial Disclosures by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 05/27/2009)
2009-05-27
1
NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP.(Blumenfeld, Jack) (Entered: 05/27/2009)
2009-05-27
1
ORDER REFERRING CASE to Magistrate Judge Leonard P. Stark for the purpose of resolving all discovery disputes (*The Court will suspend its non-case dispositive motions procedure due to this referral). Signed by Judge Joseph J. Farnan, Jr. on 5/27/2009. (nms) (Entered: 05/28/2009)
2009-05-27
1
Minute Entry for proceedings held before Judge Joseph J. Farnan, Jr. - Scheduling Conference held on 5/27/2009. This case will be referred to Judge Stark for discovery disputes. Parties will retain an outside mediator for ADR. The Court anticipates a Pretrial Conference to be held in November 2010, and a Trial to be held in December 2010. Counsel is directed to submit a Proposed Scheduling Order to the Court within two weeks of today reflecting the discussions from this Scheduling Conference. (Court Reporter Leonard Dibbs.) (nms)
2009-05-27
1
No Actions
Official Transcript of Scheduling Conference held on 05-27-09 before Judge Joseph J. Farnan, Jr. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/22/2009. Redacted Transcript Deadline set for 7/2/2009. Release of Transcript Restriction set for 8/31/2009. (lad) (Entered: 06/01/2009)
2009-06-01
1
PROPOSED ORDER - RULE 16 SCHEDULING ORDER by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc.. (Attachments: # 1 Letter to the Honorable Joseph J. Farnan, Jr.)(Blumenfeld, Jack) (Entered: 06/09/2009)
2009-06-09
1
RULE 16 SCHEDULING ORDER: Joinder of Parties due by 9/18/2009. Amended Pleadings due by 11/23/2009. Interrogatories, identification of all fact witnesses, and document production due by 12/18/2009. Discovery Disputes referred to Magistrate Judge Stark. Dispositive Motions due by 8/6/2010. Claims Construction Opening Brief due by 1/22/2010. Claim Construction Answering Briefs due by 2/5/2010. Markman Hearing set for 2/26/2010 in Courtroom 4B before Judge Joseph J. Farnan, Jr.. Pretrial Conference set for 11/4/2010 in Courtroom 4B before Judge Joseph J. Farnan, Jr.. Bench Trial set for 12/7/2010 in Courtroom 4B before Judge Joseph J. Farnan, Jr. (see Order for further details). Signed by Judge Joseph J. Farnan, Jr. on 6/11/2009. (nms) (Entered: 06/12/2009)
2009-06-11
1
ORDER REGARDING DISCOVERY MATTER PROCEDURES. Signed by Judge Leonard P. Stark on 6/12/2009. (rpg) (Entered: 06/12/2009)
2009-06-12
1
NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s First Set of Interrogatories (Nos. 1-7) and Mylan Pharmaceuticals Inc.'s First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-55) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 07/15/2009)
2009-07-15
1
MOTION for Pro Hac Vice Appearance of Attorney Dieter H. Hellmoldt and Matthew A. Argenti of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/16/2009)
2009-07-16
1
SO ORDERED, re 29 MOTION for Pro Hac Vice Appearance of Attorney Dieter H. Hellmoldt and Matthew A. Argenti of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc.. Signed by Judge Joseph J. Farnan, Jr. on 7/17/2009. (nms)
2009-07-17
1
No Actions
NOTICE OF SERVICE of Defendant's Responses to Plaintiffs' First Set of Interrogatories AND Defendant's Responses to Plaintiffs' First Set of Requests for Production of Documents & Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 08/19/2009)
2009-08-19
1
Letter to The Honorable Joseph J. Farnan, Jr. from Jack B. Blumenfeld regarding exchange of names of proposed mediators - re 23 Order Referring Case to Magistrate Judge,. (Blumenfeld, Jack) (Entered: 09/01/2009)
2009-09-01
1
MOTION to Consolidate Cases - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Blumenfeld, Jack) (Entered: 10/16/2009)
2009-10-16
1
MOTION to Consolidate Cases - filed by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP. (Blumenfeld, Jack) (Entered: 10/16/2009)
2009-10-16
1
NOTICE OF MOTION by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP re (32 in 1:09-cv-00184-JJF-LPS, 13 in 1:09-cv-00703-JJF) MOTION to Consolidate Cases ; Requesting the following Motion Day: November 19, 2009 at 10:00 a.m. (Blumenfeld, Jack) (Entered: 10/16/2009)
2009-10-16
1
NOTICE OF MOTION by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP re (32 in 1:09-cv-00184-JJF-LPS, 13 in 1:09-cv-00703-JJF) MOTION to Consolidate Cases ; Requesting the following Motion Day: November 19, 2009 at 10:00 a.m. (Blumenfeld, Jack) (Entered: 10/16/2009)
2009-10-16
1
Remark: Set Answering Brief Deadline re 32 MOTION to Consolidate Cases. Answering Brief/Response due date per Local Rules is 11/2/2009. (nms)
2009-10-28
1
No Actions
NOTICE of Withdrawal of Motion by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP re (32 in 1:09-cv-00184-JJF-LPS, 13 in 1:09-cv-00703-JJF) MOTION to Consolidate Cases (Blumenfeld, Jack) (Entered: 10/29/2009)
2009-10-29
1
NOTICE of Withdrawal of Motion by Research Foundation of State University of New York, New York University, Galderma Laboratories Inc., Galderma Laboratories LP re (32 in 1:09-cv-00184-JJF-LPS, 13 in 1:09-cv-00703-JJF) MOTION to Consolidate Cases (Blumenfeld, Jack) (Entered: 10/29/2009)
2009-10-29
1
NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Second Set of Interrogatories and Mylan Pharmaceuticals Inc.'s Second Set of Requests for Production of Documents and Things to Plaintiffs by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 11/19/2009)
2009-11-19
1
PROPOSED Stipulated Protective Order by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) Modified on 11/25/2009 (nms). (Entered: 11/24/2009)
2009-11-24
1
PROPOSED Stipulated Order Establishing Protocol for Discovery of Electronic Information by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) Modified on 11/25/2009 (nms). (Entered: 11/24/2009)
2009-11-24
1
ORDER Granting 36 Proposed Stipulated Protective Order filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Joseph J. Farnan, Jr. on 11/25/2009. (nms) (Entered: 11/25/2009)
2009-11-25
1
MOTION for Pro Hac Vice Appearance of Attorney Omar Jabri of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 11/25/2009)
2009-11-25
1
SO ORDERED, re 37 Proposed Stipulated Order Establishing Protocol For Discovery of Electronic Information, filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Joseph J. Farnan, Jr. on 11/25/2009. (nms)
2009-11-25
1
No Actions
SO ORDERED, re 39 MOTION for Pro Hac Vice Appearance of Attorney Omar Jabri of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc.. Signed by Judge Joseph J. Farnan, Jr. on 11/30/2009. (nms)
2009-11-30
1
No Actions
Letter to The Honorable Joseph J. Farnan, Jr. from Jack B. Blumenfeld regarding proposed mediators - re Scheduling Conference,,. (Blumenfeld, Jack) (Entered: 12/01/2009)
2009-12-01
1
SO ORDERED, re 36 Stipulated Protective Order by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. Signed by Judge Leonard P. Stark on 12/1/2009. (rpg)
2009-12-01
1
No Actions
SO ORDERED, re 37 PROPOSED Stipulated Order Establishing Protocol for Discovery of Electronic Information by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. Signed by Judge Leonard P. Stark on 12/1/2009. (rpg)
2009-12-01
1
No Actions
ORAL ORDER : If parties have not reached agreement as to mediator by December 8, 2009, counsel shall submit proposed names to Court for selection. Signed by Judge Joseph J. Farnan, Jr. on 12/3/2009. (dlk)
2009-12-03
1
No Actions
Letter to The Honorable Joseph J. Farnan, Jr. from Jack B. Blumenfeld regarding inability of parties to agree on mediator - re Oral Order. (Blumenfeld, Jack) (Entered: 12/08/2009)
2009-12-08
1
ORAL ORDER: The Court has reviewed the parties proposals regarding selection of a Mediator and has selected the Honorable John J. Hughes as Mediator in this action.. ORDERED by Judge Joseph J. Farnan, Jr. on 12/9/2009. (dlk)
2009-12-09
1
No Actions
ORDER appointing John J. Hughes, Esq. as mediator. Signed by Judge Joseph J. Farnan, Jr. on 12/11/2009. (nms) (Entered: 12/11/2009)
2009-12-11
1
NOTICE OF SERVICE of Defendant's Supplemental Responses to Plaintiffs' First Set of Interrogatories; Defendant's Responses to Plaintiffs' Second Set of Interrogatories; and Defendant's Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/18/2009)
2009-12-18
1
STIPULATION -- JOINT EXPERT DISCOVERY STIPULATION by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) (Entered: 12/23/2009)
2009-12-23
1
SO ORDERED, re 44 Joint Expert Discovery Stipulation, filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc., Mylan Pharmaceuticals Inc. (see Stipulation for further details). Signed by Judge Joseph J. Farnan, Jr. on 12/29/2009. (nms)
2009-12-29
1
No Actions
NOTICE Of Service of Defendant's Corrected Supplemental Responses to Plaintiffs' First Set of Interrogatories (Related document: 43 Notice of Service), filed by Mylan Pharmaceuticals Inc..(Moore, David) Modified on 1/4/2010 (nms). (Entered: 12/30/2009)
2009-12-30
1
ORAL ORDER DENYING Plaintiffs' email of 11/23/2009 requesting Mylan to provide notice of approval of ANDA 90-855. ORDERED by Judge Joseph J. Farnan, Jr. on 12/28/2009. (dlk)
2010-01-04
1
No Actions
Set/Reset Scheduling Order Deadlines: Markman Hearing set for 3/23/2010 at 10:00 AM in Courtroom 4B before Judge Joseph J. Farnan, Jr.. Tutorial on the technology set for 3/23/2010. The2/25/2010 tutorial and the 2/26/2010 Markman are CANCELED.(dlk)
2010-01-15
1
No Actions
STIPULATION TO EXTEND TIME to file Opening and Responsive Markman Briefs and extension of fact discovery deadline to -- -- Opening Markman Briefs - February 12, 2010; Responsive Markman Briefs - February 26, 2010; Fact Discovery completion - April 30, 2010 - filed by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) (Entered: 01/25/2010)
2010-01-25
1
NOTICE OF SERVICE of Plaintiffs' Supplemental Response to Mylan's Interrogatory No. 4 by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 01/25/2010)
2010-01-25
1
ORDER Granting 46 STIPULATION TO EXTEND TIME to file Opening and Responsive Markman Briefs, and extension of fact discovery deadline, filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc., Mylan Pharmaceuticals Inc. (Set Deadlines: Claims Construction Answering Brief due by 2/26/2010, Claims Construction Opening Brief due by 2/12/2010, Fact Discovery due by 4/30/2010). Signed by Judge Joseph J. Farnan, Jr. on 1/29/2010. (nms) (Entered: 01/29/2010)
2010-01-29
1
Order Setting Teleconference: Discovery Telephone Conference set for 2/16/2010 02:00 PM before Judge Leonard P. Stark. ( Please see order for complete details regarding letter submission due date(s) ). Signed by Judge Leonard P. Stark on 2/3/2010. (rpg) (Entered: 02/03/2010)
2010-02-03
1
ORDER REFERRING all claim construction issues to Magistrate Judge Leonard P. Stark (see Order for further details). Signed by Judge Joseph J. Farnan, Jr. on 2/4/2010. (nms) (Entered: 02/05/2010)
2010-02-04
1
Letter to Hon. Leonard P. Stark from Jack B. Blumenfeld regarding Response to Mylan's February 11, 2010 letter. (Attachments: # 1 Exhibit A-E)(Blumenfeld, Jack) (Entered: 02/12/2010)
2010-02-12
1
Letter to The Honorable Leonard P. Stark from David E. Moore regarding discovery contentions. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Moore, David) (Entered: 02/12/2010)
2010-02-12
1
CLAIM CONSTRUCTION OPENING BRIEF filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits 1 through 3, # 2 Exhibits 4 through 5, # 3 Exhibits 6 through 13, # 4 Exhibits 14 through 17)(Blumenfeld, Jack) (Entered: 02/12/2010)
2010-02-12
1
DECLARATION of Guy F. Webster, M.D., Ph.D. re 53 Claim Construction Opening Brief, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits A through C, # 2 Exhibits D through F, # 3 Exhibit G, # 4 Exhibit H (Part 1), # 5 Exhibit H (Part 2), # 6 Exhibits I through L)(Blumenfeld, Jack) Modified on 2/16/2010 (nms). (Entered: 02/12/2010)
2010-02-12
1
CLAIM CONSTRUCTION OPENING BRIEF filed by Mylan Pharmaceuticals Inc.. (Moore, David) (ntl). (Entered: 02/12/2010)
2010-02-12
1
DECLARATION of Omar Jabri in Support of 55 Opening Claim Construction Brief (Volume I of II, Exhibits 1 - 14), by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8 - (see replacement document at part 17), # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14 (part 1 of 2), # 15 Exhibit 14 (part 2 of 2))(Moore, David) Modified on 2/16/2010 (nms). (Additional attachment(s) added on 2/16/2010: # 16 Main document) (ntl). (Additional attachment(s) added on 3/2/2010: # 17 Exhibit 8 replaced on 3/2/10) (rbe). Modified on 3/2/2010 (rbe). (Entered: 02/12/2010)
2010-02-12
1
DECLARATION of Omar Jabri re 55 Claim Construction Opening Brief in Support of 55 Opening Claim Construction Brief (Volume II of II - Exhibits 15 - 46), by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 15, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26, # 13 Exhibit 27-29, # 14 Exhibit 30-34, # 15 Exhibit 35-37, # 16 Exhibit 38-40, # 17 Exhibit 41-44, # 18 Exhibit 45-46)(Moore, David) Modified on 2/16/2010 (nms). (Additional attachment(s) added on 2/16/2010: # 19 Main document) (ntl). (Entered: 02/12/2010)
2010-02-12
1
NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Interrogatory No. 16 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/15/2010)
2010-02-15
1
NOTICE to Take Deposition of Galderma Laboratories Inc. and Galderma Laboratories, L.P. on February 26, 2010 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/16/2010)
2010-02-16
1
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 2/16/2010. (Court Reporter: Deanna Warner - Hawkins Rptg.) (ntl)
2010-02-16
1
No Actions
CORRECTING ENTRY: the main documents for D.I. 55, 56 and 57 were removed and replaced with corrected documents re certificates of service were incorrect. (ntl)
2010-02-16
1
No Actions
NOTICE OF SERVICE of (i) Notice of Deposition of S. Wayne Talton, (ii) Notice of Deposition of David Wargo and (iii) Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) of Mylan Pharmaceuticals Inc. by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Noreika, Maryellen) (Entered: 02/22/2010)
2010-02-22
1
ORDER Setting Markman Hearing: ( Markman Hearing set for 3/23/2010 10:00 AM in Courtroom 6C before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 2/24/2010. (rpg) (Entered: 02/24/2010)
2010-02-24
1
CLAIM CONSTRUCTION ANSWERING BRIEF re 53 Claim Construction Opening Brief, filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/26/2010)
2010-02-26
1
Supplemental DECLARATION of Omar Jabri re 62 Claim Construction Answering Brief, by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 47-55, # 2 Exhibit 56-64, # 3 Exhibit 65-70, # 4 Exhibit 71, # 5 Exhibit 72-75)(Moore, David) Modified on 3/1/2010 (nms). (Entered: 02/26/2010)
2010-02-26
1
CLAIM CONSTRUCTION ANSWERING BRIEF re 55 Claim Construction Opening Brief filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) (Entered: 02/26/2010)
2010-02-26
1
NOTICE OF SERVICE of 1) Galderma's Objections and Responses to Mylan's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6); and 2) Plaintiffs' Second Supplemental Response to Mylan's Interrogatory No. 4 by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 03/02/2010)
2010-03-02
1
CORRECTING ENTRY: Per counsel's request (Potter Anderson & Corroon LLP), Help Desk replaced Exhibit 8 to Declaration, DI 56 . New Exhibit 8 appears as Part 17 to DI 56. (rbe)
2010-03-02
1
No Actions
Letter to Hon. Joseph J. Farnan, Jr.; Hon. Leonard P. Stark from Jack B. Blumenfeld regarding Case status. (Blumenfeld, Jack) (Entered: 03/09/2010)
2010-03-09
1
NOTICE of Issuance of Subpoenas upon Nungavaram S. Ramamurthy, Susan Sipos, Ashok R. Amin, Robert A. Ashley, Irving Feit, and Lorne M. Golub by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 03/11/2010)
2010-03-11
1
NOTICE of Issuance of Subpoena upon Hoffman & Baron by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 03/11/2010)
2010-03-11
1
CORRECTING ENTRY: Per request to the Help Desk, NOTICE of Issuance of Subpoenas upon Nungavaram S. Ramamurthy, Susan Sipos, Ashok R. Amin, Robert A. Ashley, Irving Feit, and Lorne M. Golub by Mylan Pharmaceuticals Inc., removed from the docket. Counsel will refile the correct document. (rbe)
2010-03-11
1
No Actions
NOTICE OF SERVICE of Amended Subpoena upon Ashok R. Amin by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/17/2010)
2010-03-17
1
NOTICE OF SERVICE of Plaintiffs' Objections and Response to Mylan Pharmaceutical Inc.'s Interrogatory No. 16 by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 03/17/2010)
2010-03-17
1
NOTICE OF SERVICE of Mylan's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/19/2010)
2010-03-19
1
Letter to Mr. Ronald Golden, Courtroom Deputy from David E. Moore, Esquire regarding Request for Permission to Have Laptop Computers in Courtroom 6C - re 61 Order, Scheduling Order. (Attachments: # 1 Text of Proposed Order)(Moore, David) (Entered: 03/19/2010)
2010-03-19
1
NOTICE OF SERVICE of Defendant's Second Supplemental Response to Plaintiffs' Interrogatory No. 2 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/19/2010)
2010-03-19
1
NOTICE of Issuance of Subpoenas upon Christopher Powala and Robert Skidmore by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 03/22/2010)
2010-03-22
1
Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing/Tutorial held on 3/23/2010. (Court Reporter: Deanna Warner - Hawkins Rptg.) (ntl)
2010-03-23
1
No Actions
NOTICE of Issuance of Subpoena upon University of Florida by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 03/26/2010)
2010-03-26
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding proposed schedule for motion briefing. (Blumenfeld, Jack) (Entered: 03/26/2010)
2010-03-26
1
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding briefing schedule - re 76 Letter. (Moore, David) (Entered: 03/29/2010)
2010-03-29
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding furtherance to Plaintiffs' March 26, 2010 letter and in response to Mylan's March 29, 2010 letter - re 77 Letter, 76 Letter. (Noreika, Maryellen) (Entered: 03/29/2010)
2010-03-29
1
ORDER Regarding Consent, Setting Briefing Schedule, and Hearing on Motion. Set Briefing Schedule: ( Motion for Preliminary Junction and Opening Brief, if any, due 4/2/2010, Answering Brief due 4/30/2010, and Reply Brief due 5/14/2010 ). ( Motion Hearing on Preliminary Injunction set for 5/24/2010 09:00 AM in Courtroom 6C before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 3/29/2010. (rpg) (Entered: 03/29/2010)
2010-03-29
1
NOTICE OF SERVICE of (i) Christopher Powala's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; (ii) Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena to Christopher Powala; (iii) Robert Skidmore's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; (iv) Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.' Subpoena to Robert Skidmore; (v) Ashok Amin's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; and (vi) Plaintiffs' Objections to Mylan Pharmaceuticals, Inc.'s Subpoena to Dr. Ashok R. Amin by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Smith, Rodger) (Entered: 03/30/2010)
2010-03-30
1
NOTICE OF SERVICE of Plaintiffs' Requests for Admission by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 03/30/2010)
2010-03-30
1
STIPULATION AMENDING SCHEDULING ORDER (see 26 Scheduling Order, and 48 Order), by Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 4/1/2010 (nms). (Entered: 03/31/2010)
2010-03-31
1
NOTICE OF SERVICE of Plaintiffs' Third Set of Interrogatories by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 04/01/2010)
2010-04-01
1
NOTICE OF SERVICE of 1. Hoffmann & Baron's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; 2. Plaintiffs' Objections and Responses to Mylan Pharamceuticals Inc.'s Subpoena to Hoffmann & Baron; 3. Irving Feit's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; 4. Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena to Irving Feit; 5. Susan Sipos' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; 6. Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena to Susan Sipos; 7. Robert Ashley's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; 8. Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena to Robert Ashley; 9. Dr. Nungavaram S. Ramamurthy's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; 10. Plaintiffs' Objections and Responses to Mylan Pharamceuticals Inc.'s Subpoena to Dr. Nungavaram S. Ramamurthy; 11. Dr. Lorne M. Golub's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena; and 12. Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena to Dr. Lorne M. Golub by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 04/01/2010)
2010-04-01
1
SO ORDERED, re 82 Stipulation to Reset Scheduling Order Deadlines: ( Fact Discovery due by 6/9/2010, Opening Expert Reports due 6/14/2010, Rebuttal Expert Reports due 7/9/2010, and Expert Discovery Deadline 7/30/2010 ). Signed by Judge Leonard P. Stark on 4/1/2010. (rpg) (Entered: 04/01/2010)
2010-04-01
1
STIPULATION Consenting to Exercise of Jurisdiction by Magistrate Judge Leonard P. Stark over Plaintiffs' Motion for Preliminary Injunction, by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. (Moore, David) Modified on 4/5/2010 (nms). (Entered: 04/01/2010)
2010-04-01
1
MOTION for Preliminary Injunction and Temporary Restraining Order - filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. Motions referred to Leonard P. Stark.(Blumenfeld, Jack) (Entered: 04/02/2010)
2010-04-02
1
SEALED OPENING BRIEF in Support re 87 MOTION for Preliminary Injunction and Temporary Restraining Order filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.Answering Brief/Response due date per Local Rules is 4/19/2010. (Attachments: # 1 Exhibit A-CC)(Blumenfeld, Jack) (Entered: 04/02/2010)
2010-04-02
1
SEALED DECLARATION of Brian Johnson re 87 MOTION for Preliminary Injunction and Temporary Restraining Order, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit 1-7)(Blumenfeld, Jack) Modified on 4/5/2010 (nms). (Entered: 04/02/2010)
2010-04-02
1
SEALED DECLARATION of Professor Jerry A. Hausman re 87 MOTION for Preliminary Injunction and Temporary Restraining Order, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit 1-8)(Blumenfeld, Jack) Modified on 4/5/2010 (nms). (Entered: 04/03/2010)
2010-04-03
1
SEALED DECLARATION of Guy F. Webster, M.D., Ph. D. re 87 MOTION for Preliminary Injunction and Temporary Restraining Order, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit 1-40)(Blumenfeld, Jack) Modified on 4/5/2010 (nms). (Entered: 04/03/2010)
2010-04-03
1
NOTICE of Issuance of Subpoena to Brian M. Gallagher with Schedule A, Attachment 1 and Certificate of Service attached by Mylan Pharmaceuticals Inc. (Horwitz, Richard) (Entered: 04/05/2010)
2010-04-05
1
ORDER Granting 86 Joint Stipulation Consenting to Exercise of Jurisdiction by Magistrate Judge Leonard P. Stark over Plaintiffs' Motion for Preliminary Injunction, filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Joseph J. Farnan, Jr. on 4/6/2010. (nms) (Entered: 04/06/2010)
2010-04-06
1
NOTICE OF SERVICE of Mylan's Interrogatory No. 17 by Mylan Pharmaceuticals Inc..(Horwitz, Richard) (Entered: 04/07/2010)
2010-04-07
1
NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena to University of Florida, College of Dentistry - Department of Periodontology by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
1
MOTION for Leave to File Amended Answer And Counterclaims - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Text of Proposed Order)Motions referred to Leonard P. Stark.(Horwitz, Richard) Modified on 4/12/2010 (nms). (Additional attachment(s) added on 5/6/2010: # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E) (nms). (Entered: 04/09/2010)
2010-04-09
1
REDACTED VERSION of 88 Opening Brief in Support, of Motion for Preliminary Injunction and Temporary Restraining Order by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits A-E, # 2 Exhibits F-L, # 3 Exhibits M-S, # 4 Exhibits T-W, # 5 Exhibits X-BB, # 6 Exhibit CC)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
1
REDACTED VERSION of 88 Opening Brief in Support, of Motion for Preliminary Injunction and Temporary Restraining Order by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits A-E, # 2 Exhibits F-L, # 3 Exhibits M-S, # 4 Exhibits T-W, # 5 Exhibits X-BB, # 6 Exhibit CC)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
2
REDACTED VERSION of 88 Opening Brief in Support, of Motion for Preliminary Injunction and Temporary Restraining Order by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits A-E, # 2 Exhibits F-L, # 3 Exhibits M-S, # 4 Exhibits T-W, # 5 Exhibits X-BB, # 6 Exhibit CC)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
2
REDACTED VERSION of 88 Opening Brief in Support, of Motion for Preliminary Injunction and Temporary Restraining Order by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits A-E, # 2 Exhibits F-L, # 3 Exhibits M-S, # 4 Exhibits T-W, # 5 Exhibits X-BB, # 6 Exhibit CC)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
2
REDACTED VERSION of 88 Opening Brief in Support, of Motion for Preliminary Injunction and Temporary Restraining Order by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits A-E, # 2 Exhibits F-L, # 3 Exhibits M-S, # 4 Exhibits T-W, # 5 Exhibits X-BB, # 6 Exhibit CC)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
2
REDACTED VERSION of 88 Opening Brief in Support, of Motion for Preliminary Injunction and Temporary Restraining Order by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits A-E, # 2 Exhibits F-L, # 3 Exhibits M-S, # 4 Exhibits T-W, # 5 Exhibits X-BB, # 6 Exhibit CC)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
2
REDACTED VERSION of 88 Opening Brief in Support, of Motion for Preliminary Injunction and Temporary Restraining Order by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits A-E, # 2 Exhibits F-L, # 3 Exhibits M-S, # 4 Exhibits T-W, # 5 Exhibits X-BB, # 6 Exhibit CC)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
2
REDACTED VERSION of 90 Declaration, of Professor Jerry A. Hausman by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits 1-8)(Blumenfeld, Jack) (Additional attachment(s) added on 4/13/2010: # 2 Main Document) (nms). (Entered: 04/09/2010)
2010-04-09
1
REDACTED VERSION of 89 Declaration, of Brian Johnson by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits 1-7)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
1
REDACTED VERSION of 91 Declaration, of Guy F. Webster, M.D., Ph.D. by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits 1-4, # 2 Exhibit 5, # 3 Exhibits 6-8, # 4 Exhibits 9-15, # 5 Exhibits 16-22, # 6 Exhibits 23-25, # 7 Exhibits 26-30, # 8 Exhibits 31-32, # 9 Exhibit 33, # 10 Exhibits 34-38, # 11 Exhibits 39-40)(Blumenfeld, Jack) (Entered: 04/09/2010)
2010-04-09
1
Remark: Set Answering Brief Deadline re 96 MOTION for Leave to File Amended Answer And Counterclaims. Answering Brief/Response due date per Local Rules is 4/26/2010. (nms)
2010-04-12
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Michael A. Berta, Tung-On (T.O.) Kong and Melissa A. Kopacz of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. Motions referred to Leonard P. Stark.(Moore, David) (Entered: 04/13/2010)
2010-04-13
1
CORRECTING ENTRY: The main document PDF for D.I. 98 has been removed and replaced with an amended version per counsel's request. The cover page for the document has been corrected. (nms)
2010-04-13
1
No Actions
NOTICE OF SERVICE of (i) Brian Gallagher's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena and (ii) Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena to Brian Gallagher by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 04/19/2010)
2010-04-19
1
SO ORDERED, re 101 MOTION for Pro Hac Vice Appearance of Attorney Michael A. Berta, Tung-On (T.O.) Kong and Melissa A. Kopacz of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 4/20/2010. (rpg)
2010-04-20
1
No Actions
NOTICE of Withdrawal of Apperance for D. Fon Muttamara-Walker by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 04/21/2010)
2010-04-21
1
SEALED ANSWERING BRIEF in Opposition re 87 MOTION for Preliminary Injunction and Temporary Restraining Order filed by Mylan Pharmaceuticals Inc..Reply Brief due date per Local Rules is 5/10/2010. (Moore, David) (Entered: 04/30/2010)
2010-04-30
1
SEALED DECLARATION of Henry F. Chambers, M.D. re 105 Answering Brief in Opposition with Exhibits A-DD, by Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 5/3/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
DECLARATION of Ronald N. Jones, M.D. re 105 Answering Brief in Opposition, by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A & B)(Moore, David) Modified on 5/3/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
SEALED DECLARATION of Jason Harper re 105 Answering Brief in Opposition, by Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 5/3/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
SEALED DECLARATION of Tung-On Kong re 105 Answering Brief in Opposition, (Volume 1 of 2) by Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 5/3/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
SEALED DECLARATION of Tung-On-Kong re 105 Answering Brief in Opposition, (Volume 2 of 2) by Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 5/3/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
SEALED DECLARATION of Philip B. Nelson, PH.D. re 105 Answering Brief in Opposition with Exhibits 1-5, by Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 5/3/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
SEALED Declaration of Barbara A. Gilchrest M.D. re 105 Answering Brief, filed by Mylan Pharmaceuticals Inc. (Attachments: Exhibits 1-22 - Volume 1 of 3). (Moore, David) Modified on 5/12/2010 (nms). Modified on 5/13/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
SEALED Declaration of Barbara A. Gilchrest, M.D. re 105 Answering Brief, filed by Mylan Pharmaceuticals Inc. (Attachments: Exhibits 1-22 - Volume 2 of 3). (Moore, David) Modified on 5/12/2010 (nms). Modified on 5/13/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
SEALED Declaration of Barbara A. Gilchrest, M.D. re 105 Answering Brief, filed by Mylan Pharmaceuticals Inc. (Attachments: Exhibits 1-22 - Volume 3 of 3). (Moore, David) Modified on 5/12/2010 (nms). Modified on 5/13/2010 (nms). (Entered: 04/30/2010)
2010-04-30
1
NOTICE OF SERVICE of Defendant's Supplemental Responses to Interrogatories Nos. 1 and 2 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 05/03/2010)
2010-05-03
1
NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Third Set of Interrogatories and Defendant's Responses and Objections to Plaintiffs' Requests for Admission by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 05/04/2010)
2010-05-04
1
Letter to The Honorable Joseph J. Farnan, Jr. from David E. Moore regarding briefing schedule regarding Mylan's motion to amend. (Moore, David) (Entered: 05/05/2010)
2010-05-05
1
PROPOSED ORDER re 117 Letter by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 05/05/2010)
2010-05-05
1
NOTICE OF SERVICE of Defendant's Supplemental Responses to Plaintiffs' Interrogatory Nos. 6 & 9 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 05/06/2010)
2010-05-06
1
MOTION for Leave to File Excess Pages - filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit A, # 2 Exhibit B)Motions referred to Leonard P. Stark.(Noreika, Maryellen) (Entered: 05/06/2010)
2010-05-06
1
Letter to The Honorable Joseph J. Farnan, Jr. from Maryellen Noreika regarding Plaintiffs' motion requesting an extension of the page limit with respect to its opposition brief - re 120 MOTION for Leave to File Excess Pages. (Noreika, Maryellen) (Entered: 05/06/2010)
2010-05-06
1
CORRECTING ENTRY: Exhibits C, D, and E have been added as attachments to D.I. 96 per counsel's request. These exhibits were inadvertently omitted. (nms)
2010-05-06
1
No Actions
Remark: Set Answering Brief Deadline re 120 MOTION for Leave to File Excess Pages. Answering Brief/Response due date per Local Rules is 5/24/2010. (nms)
2010-05-07
1
No Actions
REDACTED VERSION of 105 Answering Brief in Opposition to MOTION for Preliminary Injunction and Temporary Restraining Order by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 05/10/2010)
2010-05-10
1
REDACTED VERSION of 106 Declaration of Henry F. Chambers, M.D. re Answering Brief in Opposition with Exhibits A-DD by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-S, # 2 Exhibit T-V, # 3 Exhibit W-DD)(Moore, David) (Entered: 05/10/2010)
2010-05-10
1
REDACTED VERSION of 108 Declaration of Jason Harper re Answering Brief in Opposition by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 05/10/2010)
2010-05-10
1
REDACTED VERSION of 109 Declaration of Tung-On Kong re Answering Brief in Opposition, (Volume 1 of 2) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8 Part 1, # 3 Exhibit 8 part 2, # 4 Exhibit 8 part 3, # 5 Exhibit 9-12, # 6 Exhibit 13-19)(Moore, David) (Entered: 05/10/2010)
2010-05-10
1
REDACTED VERSION of 110 Declaration of Tung-On-Kong re Answering Brief in Opposition, (Volume 2 of 2) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 20-21, # 2 Exhibit 22-24, # 3 Exhibit 25-27, # 4 Exhibit 28-30)(Moore, David) (Entered: 05/10/2010)
2010-05-10
1
REDACTED VERSION of 111 Declaration of Philip B. Nelson, PH.D. re Answering Brief in Opposition with Exhibits 1-5, by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-5)(Moore, David) (Entered: 05/10/2010)
2010-05-10
1
REDACTED VERSION of 112 Declaration of Barbara A. Gilchrest M.D. filed by Mylan Pharmaceuticals Inc. (Volume 1 of 3), by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5 part 1-1, # 3 Exhibit 5 part 1-2, # 4 Exhibit 5 part 1-3)(Moore, David)(nms). Modified on 5/12/2010 (nms). (Entered: 05/10/2010)
2010-05-10
1
REDACTED VERSION of 113 Declaration of Barbara A. Gilchrest, M.D. filed by Mylan Pharmaceuticals Inc. (Volume 2 of 3), by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 5 part 2-1, # 2 Exhibit 5 part 2-1, # 3 Exhibit 6 part 1, # 4 Exhibit 6 part 2)(Moore, David). Modified on 5/12/2010 (nms). (Entered: 05/10/2010)
2010-05-10
1
REDACTED VERSION of 114 Declaration of Barbara A. Gilchrest, M.D. filed by Mylan Pharmaceuticals Inc. (Volume 3 of 3) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 7-12, # 2 Exhibit 13-19, # 3 Exhibit 20 part 1, # 4 Exhibit 20 part 2, # 5 Exhibit 20 part 3, # 6 Exhibit 20 part 4, # 7 Exhibit 21-22)(Moore, David)(nms). Modified on 5/12/2010 (nms). (Entered: 05/10/2010)
2010-05-10
1
NOTICE OF SERVICE of Mylan's First Set of Requests for Admission to Plaintiffs; Mylan's Interrogatory No. 18; and Mylan's Third Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 05/10/2010)
2010-05-10
1
ORDER Granting 118 Proposed Order, filed by Mylan Pharmaceuticals Inc., (Reset Briefing Schedule: re 96 MOTION for Leave to File AN AMENDED ANSWER AND COUNTERCLAIMS, Answering Brief due 5/7/2010)(see Order for further details). Signed by Judge Joseph J. Farnan, Jr. on 5/11/2010. (nms) (Entered: 05/11/2010)
2010-05-11
1
CORRECTING ENTRY: D.I. 104 has been removed from the docket per the directive in D.I. 132 . (nms)
2010-05-11
1
No Actions
Official Transcript of Markman Hearing held on 3/23/2010 before Judge Leonard P. Stark. Court Reporter/Transcriber Deanna Warner Hawkins Court Reporter,Telephone number (302) 573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/2/2010. Redacted Transcript Deadline set for 6/14/2010. Release of Transcript Restriction set for 8/10/2010. (rpg) (Entered: 05/12/2010)
2010-05-12
1
REPORT AND RECOMMENDATION Regarding Claim Construction. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 6/1/2010. Signed by Judge Leonard P. Stark on 5/12/2010. (rpg)
2010-05-12
1
NOTICE of Issuance of Subpoena to David Pfeiffer of Nitric Bio, Inc. by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 05/12/2010)
2010-05-12
1
NOTICE requesting Clerk to remove John M. Desmarais as co-counsel. Reason for request: no longer with Kirkland & Ellis LLP. (Blumenfeld, Jack) (Entered: 05/12/2010)
2010-05-12
1
ANSWERING BRIEF in Opposition re 96 MOTION for Leave to File An Amended Answer And Counterclaims, filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.Reply Brief due date per Local Rules is 5/24/2010. (Attachments: # 1 Exhibits A-M, # 2 Exhibit N, # 3 Exhibits O-T)(Blumenfeld, Jack) Modified on 5/13/2010 (nms). (Entered: 05/12/2010)
2010-05-12
1
CORRECTING ENTRY: The main document PDFs for D.I. 128, 129, and 130 have been removed and replaced with amended versions per counsel's request. The new documents modified the document description from "Expert Report" to "Declaration". All docket texts relating to this filing have been amended accordingly. (nms)
2010-05-12
1
No Actions
CORRECTING ENTRY: The hard copy filings of D.I. 112, 113, and 114 have been replaced with corrected versions per counsel's request. The title of the documents has been changed. (nms)
2010-05-13
1
No Actions
SEALED REPLY BRIEF re 87 MOTION for Preliminary Injunction and Temporary Restraining Order, filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit DD)(Blumenfeld, Jack) Modified on 5/17/2010 (nms). (Entered: 05/14/2010)
2010-05-14
1
SEALED Supplemental DECLARATION of Guy F. Webster, M.D., PH. D. re 138 Reply Brief In Support of Plaintiffs' Motion for Preliminary Injunction, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits 41-73)(Blumenfeld, Jack) Modified on 5/17/2010 (nms). (Entered: 05/14/2010)
2010-05-14
1
SEALED Supplemental DECLARATION of Jerry A. Hausman re 138 Reply In Support of Plaintiffs' Motion for Preliminary Injunction, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits 9-13)(Blumenfeld, Jack) Modified on 5/17/2010 (nms). (Entered: 05/14/2010)
2010-05-14
1
Remark: the Preliminary Injunction hearing on 5/24/10 at 9:00 a.m. will take place in Courtroom 2A. (ntl)
2010-05-20
1
No Actions
REDACTED VERSION of 138 Reply Brief, in Support of Motion for Preliminary Injunction and Temporary Restraining Order by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit DD)(Blumenfeld, Jack) (Entered: 05/21/2010)
2010-05-21
1
REDACTED VERSION of 139 Declaration, (Supplemental) of Guy F. Webster, M.D., PH. D. by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits 41-49, # 2 Exhibits 50-54, # 3 Exhibits 55-59, # 4 Exhibits 60-67, # 5 Exhibits 68-69, # 6 Exhibits 70-73)(Blumenfeld, Jack) (Entered: 05/21/2010)
2010-05-21
1
REDACTED VERSION of 140 Declaration, (Supplemental) of Jerry A. Hausman by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits 9-13)(Blumenfeld, Jack) (Entered: 05/21/2010)
2010-05-21
1
REPLY BRIEF re 96 MOTION for Leave to File An Amended Answer and Counterclaims, filed by Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 5/24/2010 (nms). (Entered: 05/21/2010)
2010-05-21
1
DECLARATION of Terry Kearney re 96 MOTION for Leave to File An Amended Answer and Counterclaims, by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-7)(Moore, David) Modified on 5/24/2010 (nms). (Entered: 05/21/2010)
2010-05-21
1
Minute Entry for proceedings held before Judge Leonard P. Stark - Motion Hearing held on 5/24/2010 re 87 MOTION for Preliminary Injunction and Temporary Restraining Order (Court Reporters: H. Triozzi, D. Hawkins - Hawkins Rptg.) (ntl)
2010-05-24
1
No Actions
Letter to The Honorable Leonard P. Stark from Richard L. Horwitz regarding issues raised during May 24, 2010 hearing. (Horwitz, Richard) (Entered: 05/25/2010)
2010-05-25
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding follow-up on issues raised during May 24, 2010 hearing. (Blumenfeld, Jack) (Entered: 05/25/2010)
2010-05-25
1
ORDER REFERRING CASE to Magistrate Judge Leonard P. Stark to hear and resolve all pretrial matters, up to and including the pretrial conference (See Order for details). Signed by Judge Joseph J. Farnan, Jr. on 5/25/2010. Motions referred to Leonard P. Stark.(dlk) (Entered: 05/25/2010)
2010-05-25
1
Letter to The Honorable Leonard P. Stark from Richard L. Horwitz regarding response to Plaintiffs letter of May 25, 2010 - re 147 Letter. (Horwitz, Richard) (Entered: 05/26/2010)
2010-05-26
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Mylan's May 25, 2010 letter - re 146 Letter. (Attachments: # 1 Exhibit)(Blumenfeld, Jack) (Entered: 05/26/2010)
2010-05-26
1
NOTICE OF SERVICE of (i) David Pfeiffer's Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena and (ii) Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Subpoena to David Pfeiffer by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 05/27/2010)
2010-05-27
1
Letter to Jack Blumenfeld, Esq. and Richard Horwitz, Esq. from Honorable Leonard P. Stark regarding decision on pending motion for a preliminary injunction. (rpg) (Entered: 05/28/2010)
2010-05-28
1
Case reassigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb)
2010-05-28
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Michael D. Nguyen of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. Motions referred to Leonard P. Stark.(Moore, David) (Entered: 06/02/2010)
2010-06-02
1
NOTICE of Issuance of Subpoena on Hoffman & Baron, LLP by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 06/08/2010)
2010-06-08
1
SO ORDERED, re 153 MOTION for Pro Hac Vice Appearance of Attorney Michael D. Nguyen of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 6/8/2010. (rpg)
2010-06-08
1
No Actions
NOTICE of Issuance of Subpoenas upon Dr. Gary White - Kaiser Permanente, and Kaiser Permanente-c/o Karla Horrison by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 06/10/2010)
2010-06-10
1
NOTICE of Issuance of Subpoena upon Dr. Riva Collins, M.D. by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 06/10/2010)
2010-06-10
1
NOTICE OF SERVICE of (i) Plaintiffs' Objections and Responses to Mylan Pharmaceuticals Inc.'s Third Set of Requests for Production of Documents and Things to Plaintiffs; and (ii) Plaintiffs' Objections and Response to Mylan Pharmaceuticals Inc.'s Interrogatory No. 18 by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 06/14/2010)
2010-06-14
1
NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Mylan Pharmaceutical Inc.'s First Set of Requests for Admission to Plaintiffs by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 06/15/2010)
2010-06-15
1
Order Setting Discovery Teleconference: Discovery Telephone Conference set for 6/28/2010 12:00 PM before Judge Leonard P. Stark. ( Please see Order for details regarding letter submissions ). Signed by Judge Leonard P. Stark on 6/15/2010. (rpg) (Entered: 06/15/2010)
2010-06-15
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding bringing the Court's attention to new case law and new facts relating to plaintiffs' motion for preliminary injunction. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Blumenfeld, Jack) (Additional attachment(s) added on 6/17/2010: # 3 Letter) (rpg). (Entered: 06/16/2010)
2010-06-16
1
CORRECTING ENTRY: letter uploaded as attachment 1 of 3 to d.i. 160 replaced per counsel's request on 6/17/2010. (rpg)
2010-06-17
1
No Actions
SEALED Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding response to plaintiffs June 16, 2010 letter - re 160 Letter,. (Moore, David) (Entered: 06/18/2010)
2010-06-18
1
NOTICE of Issuance of Amended Subpoena upon Southern California Permanente Medical Group by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 06/18/2010)
2010-06-18
1
ORAL ORDER by Judge Leonard P. Stark on 6/21/10 re 87 MOTION for Preliminary Injunction and Temporary Restraining Order: The parties are directed not to submit any additional letters or other filings relating to the pending motion for a preliminary injunction (D.I. 87 ) without first seeking leave to do so or unless there is a further order of the Court with respect to additional filings.(ntl)
2010-06-21
1
No Actions
NOTICE OF SERVICE of Mylan's Supplemental 26(a)(1) Initial Disclosures; and Fourth Supplemental Response to Interrogatory No. 2 and First Supplemental Response to Interrogatory No. 12 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 06/22/2010)
2010-06-22
1
SEALED Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding the June 28, 2010 discovery teleconference (with Exs. A-P) - re 159 Order Setting Teleconference. (Moore, David) (Entered: 06/23/2010)
2010-06-23
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding discovery teleconference scheduled for June 28, 2010. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Blumenfeld, Jack) (Entered: 06/23/2010)
2010-06-23
1
ORDER ADOPTING MAGISTRATE JUDGE'S REPORT AND RECOMMENDATIONS ABSENT TIMELY OBJECTION for 134 Report and Recommendations. Signed by Chief Judge Gregory M. Sleet on 6/24/2010. (asw)
2010-06-24
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Mylan's June 23, 2010 letter - re 164 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Noreika, Maryellen) (Entered: 06/24/2010)
2010-06-24
1
SEALED Letter to The Honorable Leonard P. Stark from David E. Moore regarding responsive discovery dispute letter - re 165 Letter. (Moore, David) (Entered: 06/24/2010)
2010-06-24
1
Official Transcript of Preliminary Injunction Hearing held on 5/24/2010 before Judge Stark. Court Reporter/Transcriber Heather M. Triozzi,Telephone number (302) 658-6697. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/15/2010. Redacted Transcript Deadline set for 7/26/2010. Release of Transcript Restriction set for 9/22/2010. (rpg) (Entered: 06/24/2010)
2010-06-24
1
NOTICE OF SERVICE of Mylan's Fifth Supplemental Response to Interrogatory No. 2 and Second Supplemental Response to Interrogatory No. 12 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 06/25/2010)
2010-06-25
1
MOTION for Pro Hac Vice Appearance of Attorney Lori P. Westin - filed by Mylan Pharmaceuticals Inc.. Motions referred to Leonard P. Stark.(Moore, David) (Entered: 06/25/2010)
2010-06-25
1
REDACTED VERSION of 161 Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding response to plaintiffs June 16, 2010 letter by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-C)(Moore, David) (Entered: 06/25/2010)
2010-06-25
1
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding further submissions relating to the pending preliminary injunction motion. (Moore, David) (Entered: 06/25/2010)
2010-06-25
1
NOTICE of Issuance of Amended Subpoena upon Dr. Lawrence Feldman by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 06/28/2010)
2010-06-28
1
MEMORANDUM ORDER GRANTING re 96 MOTION for Leave to File Amended Answer And Counterclaims - filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 6/28/2010. (rpg)
2010-06-28
1
ORDER granting 87 Motion for Preliminary Injunction. ( Parties shall submit, a proposed form of Order consistent with and giving effect to the rulings set forth in the Memorandum Opinion issued this date ). Signed by Judge Leonard P. Stark on 6/28/2010. (rpg) (Entered: 06/28/2010)
2010-06-28
1
SEALED MEMORANDUM OPINION re 176 ORDER granting 87 Motion for Preliminary Injunction. Signed by Judge Leonard P. Stark on 6/28/2010. (rpg)
2010-06-28
1
ORDER directing the parties to submit a joint proposed redacted version re 177 SEALED MEMORANDUM OPINION re 176 ORDER granting 87 Motion for Preliminary Injunction by no later than 7/2/2010. Signed by Judge Leonard P. Stark on 6/28/2010. (rpg) (Entered: 06/28/2010)
2010-06-28
1
NOTICE OF SERVICE of Mylan's Sixth Supplemental Response to Interrogatory No. 2 and Third Supplemental Response to Interrogatory No. 12 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 06/28/2010)
2010-06-28
1
ORAL ORDER by Judge Leonard P. Stark: Given the issuance of the Court's preliminary injunction opinion today, the discovery teleconference scheduled for 12:00 PM on 6/28/2010 is RESCHEDULED for 4:00 PM on 6/28/2010. Plaintiffs' counsel shall initiate the telephone conference to (302) 573-4573. (rpg)
2010-06-28
1
No Actions
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 6/28/2010. (Court Reporter B. Gaffigan.) (ntl)
2010-06-28
1
No Actions
Official Transcript of Telephone Conference held on Monday, June 28, 2010 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/20/2010. Redacted Transcript Deadline set for 7/30/2010. Release of Transcript Restriction set for 9/27/2010. (bpg) (Entered: 06/29/2010)
2010-06-29
1
SO ORDERED, re 171 MOTION for Pro Hac Vice Appearance of Attorney Lori P. Westin filed by Mylan Pharmaceuticals Inc. Ordered by Chief Judge Gregory M. Sleet on 6/29/2010. (asw)
2010-06-29
1
No Actions
REDACTED VERSION of 164 Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding the June 28, 2010 discovery teleconference by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-P)(Moore, David) (Entered: 06/30/2010)
2010-06-30
1
NOTICE of Issuance of Second Amended Subpoena upon Dr. Lawrence Feldman by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 07/01/2010)
2010-07-01
1
REDACTED VERSION of 168 Letter to The Honorable Leonard P. Stark from David E. Moore regarding responsive discovery dispute letter by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-B)(Moore, David) (Entered: 07/01/2010)
2010-07-01
1
NOTICE OF SERVICE of 1) Plaintiffs' Third Supplemental Response to Mylan's Interrogatory No. 4 and 2) Plaintiffs' Supplemental Objections and Responses to Mylan Pharmaceutical Inc.'s First Set of Requests for Admission to Plaintiffs by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 07/01/2010)
2010-07-01
1
NOTICE OF SERVICE of Second Supplemental Response to Interrogatory No. 6, Supplemental Response to Interrogatory No. 10, and Supplemental Response to Interrogatory No. 11 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 07/01/2010)
2010-07-01
1
PROPOSED ORDER ON PRELIMINARY INJUNCTION by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld enclosing Proposed Order)(Blumenfeld, Jack) (Entered: 07/01/2010)
2010-07-01
1
PROPOSED ORDER Regarding Amended Scheduling Order by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. (Attachments: # 1 Letter to Judge Stark)(Blumenfeld, Jack) (Entered: 07/01/2010)
2010-07-01
1
ORDER on Preliminary Injunction. Signed by Judge Leonard P. Stark on 7/1/2010. (rpg) (rpg). (Entered: 07/02/2010)
2010-07-01
1
Letter to The Honorable Leonard P. Stark from David E. Moore regarding Stipulation extending the time to file a motion for reargument - re 176 Order on Motion for Preliminary Injunction,. (Moore, David) (Entered: 07/02/2010)
2010-07-02
1
STIPULATION TO EXTEND TIME to file a motion for reargument to July 20, 2010 - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/02/2010)
2010-07-02
1
CORRECTING ENTRY: d.i. 188 notice of electronic filing regenerated. (rpg)
2010-07-02
1
No Actions
REDACTED VERSION of 177 SEALED MEMORANDUM OPINION re 176 ORDER granting 87 Motion for Preliminary Injunction. Signed by Judge Leonard P. Stark on 6/28/2010. (rpg) (Entered: 07/06/2010)
2010-07-06
1
SO ORDERED, re 190 STIPULATION TO EXTEND TIME to file a motion for reargument to July 26, 2010 filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 7/6/10. (ntl)
2010-07-06
1
No Actions
ORAL ORDER by Judge Leonard P. Stark: The parties shall file letters, not to exceed 3 pages each, advising the Court of their position on the pending Motion to Dismiss Exceptional Case Claims (D.I. 12 ), filed by Defendant Mylan on April 15, 2009, in light of subsequent case developments. Such letters shall be filed no later than July 13, 2010. (rpg)
2010-07-06
1
No Actions
NOTICE OF SERVICE of 1) Hoffmann & Baron's Objections and Responses to Mylan Pharmaceutical Inc.'s Subpoena; 2) Plaintiffs' Objections and Responses to Mylan Pharmaceutical Inc.'s Subpoena to Hoffmann & Baron; 3) Plaintiffs' Objections and Responses to Mylan Pharmaceutical Inc.'s Subpoena to Dr. Gary White; 4) Plaintiffs' Objections and Responses to Mylan Pharmaceutical Inc.'s Subpoena to Kaiser Permanente; 5) Plaintiffs' Objections and Responses to Mylan Pharmaceutical Inc.'s Subpoena to Riva Collins, M.D. and 6) Plaintiffs' Objections and Responses to Mylan Pharmaceutical Inc.'s Subpoena to Southern California Permanente Medial Group by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 07/07/2010)
2010-07-07
1
NOTICE of POSTING OF PRELIMINARY INJUNCTION BOND by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York (Blumenfeld, Jack) (Entered: 07/08/2010)
2010-07-08
1
SO ORDERED, re 187 Proposed Order, filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc., Mylan Pharmaceuticals Inc. Set Deadlines: ( Pretrial Conference set for 1/26/2011 10:00 AM in Courtroom 2A before Judge Leonard P. Stark. Four (4) day Trial set for 2/14,15,16,17/2011. Day 1 to begin at 09:30 AM, and days 2 through 4 to begin at 9:00 AM in Courtroom 2A before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 7/9/2010. (rpg) (Entered: 07/09/2010)
2010-07-09
1
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding Mylan's position on its April 15, 2009 Motion to Dismiss Exceptional Case Claims, in accordance with the Court's July 6, 2010 Order - re 12 MOTION to Dismiss for Failure to State a Claim [MYLAN'S MOTION TO DISMISS PLAINTIFFS' EXCEPTIONAL CASE CLAIMS], Oral Order,. (Moore, David) (Entered: 07/13/2010)
2010-07-13
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding Mylan's Motion to Dismiss - re 17 Answering Brief in Opposition,. (Attachments: # 1 Exhibit A-B and D-G, # 2 Exhibit C (under seal))(Blumenfeld, Jack) (Entered: 07/13/2010)
2010-07-13
1
SEALED EXHIBIT re 196 Letter Exhibit C by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) (Entered: 07/13/2010)
2010-07-13
1
REDACTED VERSION of 197 Exhibit to a Document by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) (Entered: 07/14/2010)
2010-07-14
1
ANSWER to 14 Answer to Complaint, Counterclaim -- Plaintiffs' Answer to Defendant Mylan Pharmaceutical, Inc.'s First Amended Counterclaims -- by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 07/19/2010)
2010-07-19
1
SEALED MOTION for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87) - filed by Mylan Pharmaceuticals Inc.. Motions referred to Leonard P. Stark.(Moore, David) (Entered: 07/26/2010)
2010-07-26
1
SEALED DECLARATION re 200 SEALED MOTION for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87) (DECLARATION OF MELISSA KOPACZ) by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/26/2010)
2010-07-26
1
SEALED DECLARATION re 200 SEALED MOTION for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87) (DECLARATION OF RANDALL S. STAFFORD, M.D., PH.D.) by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/26/2010)
2010-07-26
1
SEALED DECLARATION re 200 SEALED MOTION for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87) (SECOND DECLARATION OF BARBARA A. GILCHREST, M.D.) by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/26/2010)
2010-07-26
1
REDACTED VERSION of 200 SEALED MOTION for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87) by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 08/04/2010)
2010-08-04
1
REDACTED VERSION of 203 Declaration, (SECOND DECLARATION OF BARBARA A. GILCHREST, M.D.) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-C, # 2 Exhibit D, # 3 Exhibit E)(Moore, David) (Entered: 08/04/2010)
2010-08-04
1
REDACTED VERSION of 201 Declaration of Melissa Kopacz in Support of Mylan's Motion for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-B, # 2 Exhibit C-E)(Moore, David) (Entered: 08/04/2010)
2010-08-04
1
REDACTED VERSION of 202 Declaration, (DECLARATION OF RANDALL S. STAFFORD, M.D., PH.D.) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-D)(Moore, David) (Entered: 08/04/2010)
2010-08-04
1
Order Setting Discovery Teleconference: Discovery Telephone Conference set for 8/20/2010 11:00 AM before Judge Leonard P. Stark. ( Please see Order for details regarding letter submissions ). Signed by Judge Leonard P. Stark on 8/10/2010. (rpg) (Entered: 08/10/2010)
2010-08-10
1
SEALED ANSWERING BRIEF in Opposition re 200 SEALED MOTION for Reargument of Plaintiffs' Motion for Preliminary Injunction and Temporary Restraining Order (DI 87) filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.Reply Brief due date per Local Rules is 8/23/2010. (Attachments: # 1 Exhibit A through F)(Blumenfeld, Jack) (Entered: 08/12/2010)
2010-08-12
1
SEALED Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding request to Court to compel Mylan to produce all notes, correspondene and other documents concerning Mylan's contact with Dr. Feldman. (Attachments: # 1 Exhibit 1-8)(Noreika, Maryellen) (Entered: 08/16/2010)
2010-08-16
1
SEALED Letter to The Honorable Leonard P. Stark from David E. Moore regarding discovery disputes - re 208 Order Setting Teleconference. (Moore, David) (Entered: 08/16/2010)
2010-08-16
1
SEALED Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding response to Mylan's August 16, 2010 letter - re 211 Letter. (Attachments: # 1 Exhibit A-C)(Noreika, Maryellen) (Entered: 08/17/2010)
2010-08-17
1
SEALED Letter to The Honorable Leonard P. Stark from David E. Moore regarding responsive discovery dispute letter - re 210 Letter,. (Moore, David) (Entered: 08/17/2010)
2010-08-17
1
REDACTED VERSION of 209 Answering Brief in Opposition, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit A-F)(Blumenfeld, Jack) (Entered: 08/19/2010)
2010-08-19
1
REDACTED VERSION of 210 Letter, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit 1-8)(Noreika, Maryellen) (Entered: 08/19/2010)
2010-08-19
1
REDACTED VERSION of 212 Letter by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit A-C)(Noreika, Maryellen) (Entered: 08/19/2010)
2010-08-19
1
Official Transcript of Telephone Conference held on Friday, August 20, 2010 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/10/2010. Redacted Transcript Deadline set for 9/20/2010. Release of Transcript Restriction set for 11/18/2010. (bpg) (Entered: 08/20/2010)
2010-08-20
1
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 8/20/2010. (Court Reporter B. Gaffigan.) (ntl)
2010-08-20
1
No Actions
SEALED Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding August 20, 2010 Order regarding submission of in camera documents - re Telephone Conference. (Moore, David) (Entered: 08/25/2010)
2010-08-25
1
NOTICE of CHANGE OF LAW FIRM AFFILIATION (G. Flattmann and C. Willgoos now affiliated with Paul Hastings; plaintiffs represented by Morris, Nichols and Paul, Hastings) by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York (Blumenfeld, Jack) (Entered: 09/02/2010)
2010-09-02
1
REDACTED VERSION of 211 Letter TO THE HONORABLE LEONARD P. STARK by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-I)(Moore, David) (Entered: 09/03/2010)
2010-09-03
1
REDACTED VERSION of 213 Letter TO THE HONORABLE LEONARD P. STARK by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-C)(Moore, David) (Entered: 09/03/2010)
2010-09-03
1
REDACTED VERSION of 218 Letter TO THE HONORABLE LEONARD P. STARK FROM DAVID E. MOORE, ESQ. REGARDING AUGUST 20, 2010 ORDER REGARDING SUBMISSION OF IN CAMERA DOCUMENTS RE TELEPHONE CONFERENCE by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/03/2010)
2010-09-03
1
{SEALED} ORDER re in camera review of documents; proposed redacted version of this Order due by 9/10/10. Signed by Judge Leonard P. Stark on 9/7/10. (ntl) (Main Document 223 replaced on 3/5/2014) (cla, ). (Entered: 09/07/2010)
2010-09-07
1
NOTICE of Issuance of Subpoena upon Ronald Baron by Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 09/09/2010)
2010-09-09
1
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding the parties' proposed redacted version of the Sealed Order - re 223 Order. (Attachments: # 1 Text of Proposed Order)(Moore, David) (Entered: 09/10/2010)
2010-09-10
1
Case reassigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
2010-09-10
1
No Actions
REDACTED VERSION of 223 Order regarding discovery. (ntl) (Entered: 09/13/2010)
2010-09-13
1
NOTICE requesting Clerk to remove Dieter H. Hellmoldt, Matthew A. Argenti and Omar Jabri of Wilson Sonsini Goodrich & Rosati as co-counsel. Reason for request: no longer working on case. (Moore, David) (Entered: 09/27/2010)
2010-09-27
1
STIPULATION regarding scheduling order dates by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/30/2010)
2010-09-30
1
NOTICE OF SERVICE of 1) Expert Report of Matthew B. Grisham, Ph.D.; and 2) Expert Report of Guy F. Webster, M.D., Ph.D. Regarding Infringement by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 10/01/2010)
2010-10-01
1
SO ORDERED, re 228 Stipulation and Order -- rebuttal expert reports exchanged 10/29/10; expert discovery cutoff 11/19/10; Mylan's response to draft proposed pretrial order due 1/7/11. Signed by Judge Leonard P. Stark on 10/1/10. (ntl)
2010-10-01
1
No Actions
NOTICE OF SERVICE of Expert Report of Henry F. Chambers, M.D., Confidential Expert Report of Philip B. Nelson, Ph.D., Expert Report of Randall S. Stafford, M.D., Ph.D., Highly Confidential Expert Report of Barbara A. Gilchrest, M.D. and Expert Report of Richard Allen Robbins, M.D. by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 10/04/2010)
2010-10-04
1
NOTICE OF SERVICE of 1) Rebuttal Expert Report of Matthew B. Grisham, Ph.D.; 2) Rebuttal Expert Report of Guy F. Webster, M.D., Ph.D. Regarding Validity; 3) Expert Report of James C. Oates, M.D.; and 4) Expert Report of John P. Murry, Jr., Ph.D. by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York.(Blumenfeld, Jack) (Entered: 10/29/2010)
2010-10-29
1
NOTICE OF SERVICE of Rebuttal Expert Report of Henry F. Chambers, M.D. and Rebuttal Expert Report of Richard Allen Robbins, M.D. by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 11/02/2010)
2010-11-02
1
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding scheduling of discovery dispute teleconference. (Moore, David) (Entered: 11/11/2010)
2010-11-11
1
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding scheduling of discovery dispute teleconference. (Moore, David) (Entered: 11/11/2010)
2010-11-11
1
ORAL ORDER: IT IS ORDERED that a status teleconference is scheduled for November 18, 2010 at 8:30 a.m. to address the disputes noted in Defendants' letter of November 11, 2010 (D.I. 233). Defendant's counsel shall initiate the teleconference call to 302-573-4573. Defendants may file a letter of up to 3 pages addressing the issues they wish to discuss in the teleconference no later than November 16 at 8:30 a.m. and Plaintiffs may file a responsive letter of up to 3 pages no later than November 17 at 8:30 a.m. ORDERED by Judge Leonard P. Stark on 11/12/10. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 11/12/2010)
2010-11-12
1
Letter to The Honorable Leonard P. Stark from David E. Moore regarding opening discovery dispute - re 234 Order Setting Teleconference,,. (Attachments: # 1 Exhibit A-C)(Moore, David) (Entered: 11/16/2010)
2010-11-16
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Mylan's November 16, 2010 letter and in connection with the November 18, 2010 8:30 a.m. teleconference - re (235 in 1:09-cv-00184-LPS) Letter, (20 in 1:10-cv-00892-LPS) Letter. (Blumenfeld, Jack) (Entered: 11/17/2010)
2010-11-17
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Mylan's November 16, 2010 letter and in connection with the November 18, 2010 8:30 a.m. teleconference - re (235 in 1:09-cv-00184-LPS) Letter, (20 in 1:10-cv-00892-LPS) Letter. (Blumenfeld, Jack) (Entered: 11/17/2010)
2010-11-17
1
ORAL ORDER by Judge Leonard P. Stark: IT IS HEREBY ORDERED that the telephone conference set for November 18, 2010 at 8:30 a.m. is hereby CANCELED and rescheduled for 11/19/2010 08:30 AM before Judge Leonard P. Stark. ( Counsel shall initiate the telephone call to (302) 573-4573 ). (rpg) (Entered: 11/18/2010)
2010-11-18
1
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 11/19/2010. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)
2010-11-19
1
No Actions
Letter to The Honorable Leonard P. Stark from David E. Moore and Jack B. Blumenfeld regarding case scheduling - re Telephone Conference. (Attachments: # 1 Exhibit A-B)(Moore, David) (Entered: 11/23/2010)
2010-11-23
1
ORDER Cancelling Trial Previously scheduled to begin on 2/14/2011 and Resetting Scheduling Order Deadlines: ( Pretrial Conference reset for 6/15/2011 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Markman Hearing set for 3/21/2011 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 6/6/2011. Bench Trial set for 7/5/2011 through 7/8/2011 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 12/1/2010 ). (rpg) (Additional attachment(s) added on 12/2/2010: # 1 Proposed Order) (rpg). (Entered: 12/02/2010)
2010-12-01
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding the Court's December 2, 2010 Order. (Blumenfeld, Jack) (Entered: 12/06/2010)
2010-12-06
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding the Court's December 2, 2010 Order. (Blumenfeld, Jack) (Entered: 12/06/2010)
2010-12-06
1
Official Transcript of Telephone Conference held on November 19, 2010 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/27/2010. Redacted Transcript Deadline set for 1/6/2011. Release of Transcript Restriction set for 3/7/2011. (bpg) (Entered: 12/06/2010)
2010-12-06
1
Letter to The Honorable Leonard P. Stark from Richard L. Horwitz, Esquire regarding response to Galderma's letter dated December 6, 2010 - re (240 in 1:09-cv-00184-LPS, 26 in 1:10-cv-00892-LPS) Letter. (Horwitz, Richard) (Entered: 12/06/2010)
2010-12-06
1
Letter to The Honorable Leonard P. Stark from Richard L. Horwitz, Esquire regarding response to Galderma's letter dated December 6, 2010 - re (240 in 1:09-cv-00184-LPS, 26 in 1:10-cv-00892-LPS) Letter. (Horwitz, Richard) (Entered: 12/06/2010)
2010-12-06
1
ORAL ORDER: the Pretrial Conference scheduled for 1/26/11 at 10:00 am is cancelled. ORDERED by Judge Leonard P. Stark on 12/6/10. (ntl)
2010-12-06
1
No Actions
Letter to The Honorable Leonard P. Stark from David E. Moore regarding Scheduling Order (on behalf of all parties). (Attachments: # 1 Exhibit A-B)(Moore, David) (Entered: 12/08/2010)
2010-12-08
1
PROPOSED ORDER Proposed Scheduling Order (on behalf of all parties) re 243 Letter by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 12/08/2010)
2010-12-08
1
SO ORDERED, re ( 31 in 1:10-cv-00892-LPS and 244 in 1:09-cv-00184-LPS) ) Proposed Order filed by Mylan Pharmaceuticals Inc. SCHEDULING ORDER: Trial Previously scheduled to begin on 2/14/2011 is hereby CANCELED. Scheduling Order Deadlines Reset. ( Pretrial Conference reset for 6/15/2011 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Markman Hearing set for 3/21/2011 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 6/6/2011. Bench Trial set for 7/5/2011 through 7/8/2011 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 12/13/2010. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg) (Entered: 12/13/2010)
2010-12-13
1
SO ORDERED, re ( 31 in 1:10-cv-00892-LPS and 244 in 1:09-cv-00184-LPS) ) Proposed Order filed by Mylan Pharmaceuticals Inc. SCHEDULING ORDER: Trial Previously scheduled to begin on 2/14/2011 is hereby CANCELED. Scheduling Order Deadlines Reset. ( Pretrial Conference reset for 6/15/2011 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Markman Hearing set for 3/21/2011 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 6/6/2011. Bench Trial set for 7/5/2011 through 7/8/2011 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 12/13/2010. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg) (Entered: 12/13/2010)
2010-12-13
1
STIPULATION [STIPULATION CONCERNING DISCOVERY IN CONSOLIDATED ACTIONS] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)
2011-01-07
1
STIPULATION [STIPULATION CONCERNING DISCOVERY IN CONSOLIDATED ACTIONS] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)
2011-01-07
1
STIPULATION AND AGREEMENT TO BE BOUND by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)
2011-01-07
1
STIPULATION AND AGREEMENT TO BE BOUND by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)
2011-01-07
1
STIPULATION TO AMEND PROTECTIVE ORDER re (38 in 1:09-cv-00184-LPS) Order, by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)
2011-01-07
1
STIPULATION TO AMEND PROTECTIVE ORDER re (38 in 1:09-cv-00184-LPS) Order, by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)
2011-01-07
1
SO ORDERED, STIPULATION TO AMEND PROTECTIVE ORDER re ( 248 in 1:09-cv-00184-LPS, 44 in 1:10-cv-00892-LPS) Stipulation filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS (rpg) (Entered: 01/10/2011)
2011-01-10
1
SO ORDERED, STIPULATION TO AMEND PROTECTIVE ORDER re ( 248 in 1:09-cv-00184-LPS, 44 in 1:10-cv-00892-LPS) Stipulation filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS (rpg) (Entered: 01/10/2011)
2011-01-10
1
SO ORDERED, re (42 in 1:10-cv-00892-LPS, 246 in 1:09-cv-00184-LPS) Stipulation regarding discovery filed by Mylan Pharmaceuticals Inc.. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS (rpg)
2011-01-10
1
No Actions
SO ORDERED, re (43 in 1:10-cv-00892-LPS, 247 in 1:09-cv-00184-LPS) Stipulation STIPULATION AND AGREEMENT TO BE BOUND by Protocol for Electronic Discovery filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)
2011-01-10
1
No Actions
NOTICE requesting Clerk to remove Michael A. Berta, formerly of Wilson Sonsini Goodrich & Rosati as co-counsel. Reason for request: no longer with firm. (Moore, David) (Entered: 02/17/2011)
2011-02-17
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding advising the Court that there have been no settlement discussions since the entry of the December 13, 2010 Scheduling Order. (Blumenfeld, Jack) (Entered: 02/25/2011)
2011-02-25
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding advising the Court that there have been no settlement discussions since the entry of the December 13, 2010 Scheduling Order. (Blumenfeld, Jack) (Entered: 02/25/2011)
2011-02-25
1
ORAL ORDER: IT IS HEREBY ORDERED that Mylan's motion to dismiss exceptional case claims (D.I. 12 ) is DENIED WITHOUT PREJUDICE to renew after judgment on the merits of the parties' infringement and validity claims. ORDERED by Judge Leonard P. Stark on 3/24/11.(ntl) (Entered: 03/24/2011)
2011-03-24
1
NOTICE requesting Clerk to remove Ron E. Shulman, Terry Kearney, Roger J. Chin as co-counsel. Reason for request: no longer with firm. (Moore, David) (Entered: 04/06/2011)
2011-04-06
1
NOTICE requesting Clerk to remove Melissa A. Kopacz as co-counsel. Reason for request: no longer with firm. (Moore, David) (Entered: 05/04/2011)
2011-05-04
1
ORAL ORDER: IT IS HEREBY ORDERED that the Pretrial Conference scheduled for 6/15/11 at 10:00 AM is CANCELLED; the Pretrial Conference is hereby rescheduled for 6/13/11 at 3:30 PM. ORDERED by Judge Leonard P. Stark on 5/23/11. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 05/23/2011)
2011-05-23
1
STIPULATION Regarding Bifurcation of Exceptional Case Claims by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. (Noreika, Maryellen) (Entered: 05/26/2011)
2011-05-26
1
SO ORDERED, re 256 Stipulation and Order re Galderma's exceptional case claims. Signed by Judge Leonard P. Stark on 5/27/11. (ntl)
2011-05-27
1
No Actions
Proposed Pretrial Order by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-11)(Noreika, Maryellen) (Entered: 06/06/2011)
2011-06-06
1
Proposed Pretrial Order by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-11)(Noreika, Maryellen) (Entered: 06/06/2011)
2011-06-06
1
SEALED EXHIBIT re (128 in 1:10-cv-00892-LPS) Proposed Pretrial Order, -- Exhibit 3 to Proposed Joint Pretrial Order -- by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 06/06/2011)
2011-06-06
1
SEALED EXHIBIT re (128 in 1:10-cv-00892-LPS) Proposed Pretrial Order, -- Exhibit 3 to Proposed Joint Pretrial Order -- by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 06/06/2011)
2011-06-06
1
MOTION for Pro Hac Vice Appearance of Attorney Joseph M. O'Malley, Jr.; Melanie R. Rupert; Ryan H. Coletti; Evan D. Diamond and Shenade Walker - filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) (Entered: 06/07/2011)
2011-06-07
1
REDACTED VERSION of (258 in 1:09-cv-00184-LPS, 129 in 1:10-cv-00892-LPS) Exhibit to a Document, by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 06/09/2011)
2011-06-09
1
REDACTED VERSION of (258 in 1:09-cv-00184-LPS, 129 in 1:10-cv-00892-LPS) Exhibit to a Document, by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 06/09/2011)
2011-06-09
1
SO ORDERED, re 259 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. O'Malley, Jr.; Melanie R. Rupert; Ryan H. Coletti; Evan D. Diamond and Shenade Walker filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc. Signed by Judge Leonard P. Stark on 6/9/11. (ntl)
2011-06-09
1
No Actions
Minute Entry for proceedings held before Judge Leonard P. Stark - Pretrial Conference held on 6/13/2011. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)
2011-06-13
1
No Actions
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding deposition objections. (Attachments: # 1 Portions of S. Talton Deposition Transcript)(Blumenfeld, Jack) (Entered: 07/03/2011)
2011-07-03
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding deposition objections. (Attachments: # 1 Portions of S. Talton Deposition Transcript)(Blumenfeld, Jack) (Entered: 07/03/2011)
2011-07-03
1
SO ORDERED, re (257 in 1:09-cv-00184-LPS, 128 in 1:10-cv-00892-LPS) Proposed Joint Pretrial Order. Signed by Judge Leonard P. Stark on 7/5/11. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)
2011-07-05
1
No Actions
Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 7/5/2011. (Court Reporter Brian Gaffigan.) (rpg)
2011-07-05
1
No Actions
Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 7/6/2011. (Court Reporters Gaffigan, Gunning.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)
2011-07-06
1
No Actions
Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 7/7/2011. (Court Reporter Brian Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)
2011-07-07
1
No Actions
Official Transcript of Pretrial Conference held on June 13, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/29/2011. Redacted Transcript Deadline set for 8/8/2011. Release of Transcript Restriction set for 10/6/2011. (bpg) (Entered: 07/08/2011)
2011-07-08
1
Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial completed on 7/8/2011. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)
2011-07-08
1
No Actions
STATEMENT -- JOINT ERRATA FOR TRIAL TRANSCRIPTS -- by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 07/20/2011)
2011-07-20
1
STATEMENT -- JOINT ERRATA FOR TRIAL TRANSCRIPTS -- by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 07/20/2011)
2011-07-20
1
STATEMENT -- Galderma's Errata for Trial Transcripts -- by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 07/20/2011)
2011-07-20
1
STATEMENT -- Galderma's Errata for Trial Transcripts -- by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 07/20/2011)
2011-07-20
1
POST TRIAL BRIEF [Opening Post-Trial Brief] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/21/2011)
2011-07-21
1
POST TRIAL BRIEF [Opening Post-Trial Brief] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/21/2011)
2011-07-21
1
Proposed Findings of Fact by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/21/2011)
2011-07-21
1
Proposed Findings of Fact by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/21/2011)
2011-07-21
1
POST TRIAL BRIEF by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Noreika, Maryellen) (Entered: 07/21/2011)
2011-07-21
1
Proposed Findings of Fact by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 07/21/2011)
2011-07-21
1
Proposed Findings of Fact by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 07/21/2011)
2011-07-21
1
NOTICE of Firm Name Change by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc. (Blumenfeld, Jack) (Entered: 07/26/2011)
2011-07-26
1
NOTICE of Firm Name Change by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc. (Blumenfeld, Jack) (Entered: 07/26/2011)
2011-07-26
1
Official Transcript of Bench Trial - Volume A held on Tuesday, July 5, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/17/2011. Redacted Transcript Deadline set for 8/29/2011. Release of Transcript Restriction set for 10/25/2011. (bpg) (Entered: 07/27/2011)
2011-07-27
1
Official Transcript of Bench Trial - Volume B held on Wednesday, July 6, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/17/2011. Redacted Transcript Deadline set for 8/29/2011. Release of Transcript Restriction set for 10/25/2011. (bpg) (Entered: 07/27/2011)
2011-07-27
1
Official Transcript of Bench Trial - Volume C held on Thursday, July 7, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/17/2011. Redacted Transcript Deadline set for 8/29/2011. Release of Transcript Restriction set for 10/25/2011. (bpg) (Entered: 07/27/2011)
2011-07-27
1
Official Transcript of Bench Trial - Volume D held on Friday, July 8, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/17/2011. Redacted Transcript Deadline set for 8/29/2011. Release of Transcript Restriction set for 10/25/2011. (bpg) (Entered: 07/27/2011)
2011-07-27
1
POST TRIAL BRIEF Responsive by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Noreika, Maryellen) (Entered: 07/29/2011)
2011-07-29
1
POST TRIAL BRIEF Responsive by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Noreika, Maryellen) (Entered: 07/29/2011)
2011-07-29
1
POST TRIAL BRIEF Responsive by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/29/2011)
2011-07-29
1
POST TRIAL BRIEF Responsive by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/29/2011)
2011-07-29
1
ORAL ORDER by Judge Leonard P. Stark: IT IS HEREBY ORDERED THAT the parties shall submit on disk, in WordPerfect format, their Proposed Findings of Fact and Conclusions of Law (D.I. 266 ; D.I. 268 ) as well as their Statement of Uncontested Facts (D.I. 257-1), and to do so no later than August 2, 2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)
2011-08-01
1
No Actions
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding enclosure of disk - re (137 in 1:10-cv-00892-LPS, 266 in 1:09-cv-00184-LPS) Proposed Findings of Fact, Oral Order,. (Moore, David) (Entered: 08/02/2011)
2011-08-02
1
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding enclosure of disk - re (137 in 1:10-cv-00892-LPS, 266 in 1:09-cv-00184-LPS) Proposed Findings of Fact, Oral Order,. (Moore, David) (Entered: 08/02/2011)
2011-08-02
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding enclosing disk of Word Perfect documents. (Blumenfeld, Jack) (Entered: 08/02/2011)
2011-08-02
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding enclosing disk of Word Perfect documents. (Blumenfeld, Jack) (Entered: 08/02/2011)
2011-08-02
1
POST TRIAL OPINION. Signed by Judge Leonard P. Stark on 9/26/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)
2011-08-26
1
POST TRIAL OPINION. Signed by Judge Leonard P. Stark on 9/26/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)
2011-08-26
1
ORDER directing the parties to submit simultaneous opening briefs ofno more than ten (10) pages on September 2,2011, and answering briefs of no more than five (5) pages on September 7, 2011, addressing the appropriate remedy in view ofthe Court's Opinion. ( Preliminary injunction previously entered will remain in effect until further Order of the Court ). Signed by Judge Leonard P. Stark on 9/26/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg) (Entered: 08/26/2011)
2011-08-26
1
ORDER directing the parties to submit simultaneous opening briefs ofno more than ten (10) pages on September 2,2011, and answering briefs of no more than five (5) pages on September 7, 2011, addressing the appropriate remedy in view ofthe Court's Opinion. ( Preliminary injunction previously entered will remain in effect until further Order of the Court ). Signed by Judge Leonard P. Stark on 9/26/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg) (Entered: 08/26/2011)
2011-08-26
1
POST TRIAL BRIEF SEALED - MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)
2011-09-02
1
POST TRIAL BRIEF SEALED - MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)
2011-09-02
1
SEALED DECLARATION re (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief DECLARATION OF PHILIP B. NELSON, PH.D., IN SUPPORT OF MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)
2011-09-02
1
SEALED DECLARATION re (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief DECLARATION OF PHILIP B. NELSON, PH.D., IN SUPPORT OF MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)
2011-09-02
1
SEALED DECLARATION re (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief DECLARATION OF ANTHONY MAURO IN SUPPORT OF MYLAN PHARMACEUTICALS INC.'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)
2011-09-02
1
SEALED DECLARATION re (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief DECLARATION OF ANTHONY MAURO IN SUPPORT OF MYLAN PHARMACEUTICALS INC.'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)
2011-09-02
1
POST TRIAL BRIEF -- Galderma's Opening Brief Regarding Remedy for Infringement -- by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibit A, # 2 Exhibits B-C)(Noreika, Maryellen) (Entered: 09/02/2011)
2011-09-02
1
SEALED EXHIBIT re 283 POST Trial Brief, -- Exhibits B-C to Galderma's Opening Brief Regarding Remedy for Infringement -- by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Noreika, Maryellen) (Entered: 09/02/2011)
2011-09-02
1
REDACTED VERSION of (155 in 1:10-cv-00892-LPS) Exhibit to a Document, (284 in 1:09-cv-00184-LPS) Exhibit to a Document, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Mylan Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 09/06/2011)
2011-09-06
1
REDACTED VERSION of (155 in 1:10-cv-00892-LPS) Exhibit to a Document, (284 in 1:09-cv-00184-LPS) Exhibit to a Document, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Mylan Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 09/06/2011)
2011-09-06
1
POST TRIAL BRIEF SEALED - Mylan's Responsive Post-Trial Brief Regarding Remedy by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/07/2011)
2011-09-07
1
SEALED REPLY BRIEF Regarding Remedy for Infringement filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Attachments: # 1 Exhibits D through H)(Noreika, Maryellen) (Entered: 09/07/2011)
2011-09-07
1
SEALED DECLARATION re (158 in 1:10-cv-00892-LPS) Reply Brief of Professor Jerry A. Hausman by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1 and 2)(Noreika, Maryellen) (Entered: 09/07/2011)
2011-09-07
1
SEALED DECLARATION re (158 in 1:10-cv-00892-LPS) Reply Brief of Professor Jerry A. Hausman by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1 and 2)(Noreika, Maryellen) (Entered: 09/07/2011)
2011-09-07
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding briefing on post-trial remedy issues complete; Galderma is available to present argument on the issues. (Blumenfeld, Jack) (Entered: 09/08/2011)
2011-09-08
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding briefing on post-trial remedy issues complete; Galderma is available to present argument on the issues. (Blumenfeld, Jack) (Entered: 09/08/2011)
2011-09-08
1
Letter to The Honorable Leonard P. Stark from Richard L. Horwitz, Esquire regarding oral argument on post-trial remedy issues - re (289 in 1:09-cv-00184-LPS, 160 in 1:10-cv-00892-LPS) Letter. (Horwitz, Richard) (Entered: 09/09/2011)
2011-09-09
1
Letter to The Honorable Leonard P. Stark from Richard L. Horwitz, Esquire regarding oral argument on post-trial remedy issues - re (289 in 1:09-cv-00184-LPS, 160 in 1:10-cv-00892-LPS) Letter. (Horwitz, Richard) (Entered: 09/09/2011)
2011-09-09
1
REDACTED VERSION of (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief [MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/09/2011)
2011-09-09
1
REDACTED VERSION of (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief [MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/09/2011)
2011-09-09
1
REDACTED VERSION of (281 in 1:09-cv-00184-LPS, 152 in 1:10-cv-00892-LPS) Declaration, [DECLARATION OF PHILIP B. NELSON, PH.D., IN SUPPORT OF MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1)(Moore, David) (Entered: 09/09/2011)
2011-09-09
1
REDACTED VERSION of (281 in 1:09-cv-00184-LPS, 152 in 1:10-cv-00892-LPS) Declaration, [DECLARATION OF PHILIP B. NELSON, PH.D., IN SUPPORT OF MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1)(Moore, David) (Entered: 09/09/2011)
2011-09-09
1
REDACTED VERSION of (281 in 1:09-cv-00184-LPS, 152 in 1:10-cv-00892-LPS) Declaration, [DECLARATION OF PHILIP B. NELSON, PH.D., IN SUPPORT OF MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1)(Moore, David) (Entered: 09/09/2011)
2011-09-09
2
REDACTED VERSION of (153 in 1:10-cv-00892-LPS, 282 in 1:09-cv-00184-LPS) Declaration, [DECLARATION OF ANTHONY MAURO IN SUPPORT OF MYLAN PHARMACEUTICALS INC.'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/09/2011)
2011-09-09
1
REDACTED VERSION of (153 in 1:10-cv-00892-LPS, 282 in 1:09-cv-00184-LPS) Declaration, [DECLARATION OF ANTHONY MAURO IN SUPPORT OF MYLAN PHARMACEUTICALS INC.'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/09/2011)
2011-09-09
1
NOTICE requesting Clerk to remove Michael D. Nguyen of Wilson Sonsini Goodrich & Rosati as co-counsel. Reason for request: No longer with firm. (Moore, David) (Entered: 09/12/2011)
2011-09-12
1
REDACTED VERSION of (158 in 1:10-cv-00892-LPS) Reply Brief, (287 in 1:09-cv-00184-LPS) Reply Brief, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit D-H)(Noreika, Maryellen) (Entered: 09/14/2011)
2011-09-14
1
REDACTED VERSION of (158 in 1:10-cv-00892-LPS) Reply Brief, (287 in 1:09-cv-00184-LPS) Reply Brief, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit D-H)(Noreika, Maryellen) (Entered: 09/14/2011)
2011-09-14
1
REDACTED VERSION of (158 in 1:10-cv-00892-LPS) Reply Brief, (287 in 1:09-cv-00184-LPS) Reply Brief, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit D-H)(Noreika, Maryellen) (Entered: 09/14/2011)
2011-09-14
2
REDACTED VERSION of (159 in 1:10-cv-00892-LPS, 288 in 1:09-cv-00184-LPS) Declaration, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 & 2)(Noreika, Maryellen) (Entered: 09/14/2011)
2011-09-14
1
REDACTED VERSION of (159 in 1:10-cv-00892-LPS, 288 in 1:09-cv-00184-LPS) Declaration, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 & 2)(Noreika, Maryellen) (Entered: 09/14/2011)
2011-09-14
1
REDACTED VERSION of (159 in 1:10-cv-00892-LPS, 288 in 1:09-cv-00184-LPS) Declaration, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 & 2)(Noreika, Maryellen) (Entered: 09/14/2011)
2011-09-14
2
REDACTED VERSION of 286 POST Trial Brief (Mylan's Sealed Post-Trial Brief Regarding Remedy) by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/14/2011)
2011-09-14
1
ORAL ORDER: IT IS HEREBY ORDERED that the Court will hear argument on the post-trial remedies on February 17, 2012 beginning at 3:00 p.m. Each side will be allocated up to one (1) hour to present its argument. ORDERED by Judge Leonard P. Stark on 1/12/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 01/12/2012)
2012-01-12
1
Minute Entry for proceedings held before Judge Leonard P. Stark - Oral Argument held on 2/17/2012. (Court Reporter Valerie Gunning.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)
2012-02-17
1
No Actions
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding bringing the Court's attention to new case law. (Attachments: # 1 Exhibit 1)(Blumenfeld, Jack) (Entered: 03/05/2012)
2012-03-05
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding bringing the Court's attention to new case law. (Attachments: # 1 Exhibit 1)(Blumenfeld, Jack) (Entered: 03/05/2012)
2012-03-05
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding bringing the Court's attention to new case law. (Attachments: # 1 Exhibit 1)(Blumenfeld, Jack) (Entered: 03/05/2012)
2012-03-05
2
SEALED MOTION UNOPPOSED MOTION TO PARTIALLY SEAL TRANSCRIPT (TRANSCRIPT OF HEARING ON 2/17/12 BEFORE THE HONORABLE LEONARD P. STARK) WITH PROPOSED ORDER - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/06/2012)
2012-03-06
1
SEALED MOTION UNOPPOSED MOTION TO PARTIALLY SEAL TRANSCRIPT (TRANSCRIPT OF HEARING ON 2/17/12 BEFORE THE HONORABLE LEONARD P. STARK) WITH PROPOSED ORDER - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/06/2012)
2012-03-06
1
Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding response to plaintiff Galderma's March 5, 2012 letter - re 299 Letter. (Moore, David) (Entered: 03/08/2012)
2012-03-08
1
ORDER granting (D.I. 300 in case 1:09-cv-00184-LPS) SEALED UNOPPOSED MOTION TO PARTIALLY SEAL TRANSCRIPT (TRANSCRIPT OF HEARING ON 2/17/12 BEFORE THE HONORABLE LEONARD P. STARK); granting 171 in case 1:10-cv-00892-LPS. Signed by Judge Leonard P. Stark on 3/12/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 03/12/2012)
2012-03-12
1
ORDER granting (D.I. 300 in case 1:09-cv-00184-LPS) SEALED UNOPPOSED MOTION TO PARTIALLY SEAL TRANSCRIPT (TRANSCRIPT OF HEARING ON 2/17/12 BEFORE THE HONORABLE LEONARD P. STARK); granting 171 in case 1:10-cv-00892-LPS. Signed by Judge Leonard P. Stark on 3/12/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 03/12/2012)
2012-03-12
1
SEALED Transcript of Hearing held on February 17, 2012 efore Judge Leonard P. Stark. (Transcript on file in Clerk's Office). (vjg) (cla, ). (Entered: 03/15/2012)
2012-03-15
1
CORRECTING ENTRY: D.I. 304 was deleted as duplicate of D.I. 303. (ntl)
2012-03-15
1
No Actions
{SEALED} MEMORANDUM ORDER re post-trial remedies (See Memorandum Order for further details). Signed by Judge Leonard P. Stark on 5/16/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)
2012-05-16
1
{SEALED} MEMORANDUM ORDER re post-trial remedies (See Memorandum Order for further details). Signed by Judge Leonard P. Stark on 5/16/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)
2012-05-16
1
ORAL ORDER: IT IS HEREBY ORDERED as follows: Because the Memorandum Order released on May 16, 2012 (D.I. 304) may contain confidential information, it has been released under seal, pending review by the parties to allow them to submit a single jointly proposed redacted version of the Memorandum Order. Such redacted version shall be submitted no later than May 18, 2012 for review by the Court. The Court will subsequently file a publicly-available version of its Memorandum Order. ORDERED by Judge Leonard P. Stark on 5/16/12.(ntl) (Entered: 05/16/2012)
2012-05-16
1
Letter to The Honorable Leonard P. Stark from David E. Moore regarding submission of redacted Memorandum Order - re 304 Memorandum and Order. (Attachments: # 1 Enclosure)(Moore, David) (Entered: 05/18/2012)
2012-05-18
1
REDACTED VERSION of 304 Memorandum Order. (ntl) (Entered: 05/25/2012)
2012-05-25
1
CASE CLOSED PER D.I. 304, 307 . (ntl)
2012-05-25
1
No Actions
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,232,572 B2; 7,211,267 B2; 5,789,395; 5,919,775. (Attachment: # 1 Memorandum Order)(ntl) (Entered: 05/30/2012)
2012-05-30
1
MOTION for Release of Bond Obligation - filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Noreika, Maryellen) (Entered: 05/30/2012)
2012-05-30
1
MOTION for Release of Bond Obligation - filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Noreika, Maryellen) (Entered: 05/30/2012)
2012-05-30
1
PROPOSED ORDER regarding Proposed Judgment by Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Cover Letter to Judge Stark)(Noreika, Maryellen) (Entered: 06/07/2012)
2012-06-07
1
PROPOSED ORDER regarding Proposed Judgment by Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Cover Letter to Judge Stark)(Noreika, Maryellen) (Entered: 06/07/2012)
2012-06-07
1
JUDGMENT (see document for further details). Signed by Judge Leonard P. Stark on 6/8/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 06/08/2012)
2012-06-08
1
JUDGMENT (see document for further details). Signed by Judge Leonard P. Stark on 6/8/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 06/08/2012)
2012-06-08
1
RESPONSE to Motion re 309 MOTION for Release of Bond Obligation [MYLAN'S OPPOSITION TO MOTION TO RELEASE BOND] filed by Mylan Pharmaceuticals Inc.. (Horwitz, Richard) (Entered: 06/13/2012)
2012-06-13
1
REPLY BRIEF re 309 MOTION for Release of Bond Obligation filed by Galderma Laboratories Inc.. (Noreika, Maryellen) (Entered: 06/21/2012)
2012-06-21
1
ORDER Setting Teleconference: A Telephone Conference is set for 7/10/2012 at 3:45 PM. Signed by Judge Leonard P. Stark on 6/26/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-01112-LPS(ntl) (rpg). (Entered: 06/26/2012)
2012-06-26
1
ORDER Setting Teleconference: A Discovery Teleconference is set for 7/10/2012 at 3:45 PM. Signed by Judge Leonard P. Stark on 6/29/12. Associated Cases: 1:09-cv-00184-LPS, 1:11-cv-01106-LPS(ntl) (Entered: 06/29/2012)
2012-06-29
1
ORDER Setting Teleconference: A Discovery Teleconference is set for 7/10/2012 at 3:45 PM. Signed by Judge Leonard P. Stark on 6/29/12. Associated Cases: 1:09-cv-00184-LPS, 1:11-cv-01106-LPS(ntl) (Entered: 06/29/2012)
2012-06-29
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding discovery dispute teleconference set for July 10, 2012 at 3:45 p.m.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Noreika, Maryellen) (Entered: 07/02/2012)
2012-07-02
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding discovery dispute teleconference set for July 10, 2012 at 3:45 p.m.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Noreika, Maryellen) (Entered: 07/02/2012)
2012-07-02
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding response to July 2, 2012 letters of Lupin and Amneal - re (62 in 1:11-cv-01106-LPS) Letter, (21 in 1:09-cv-00483-LPS, 29 in 1:10-cv-01112-LPS) Letter. (Noreika, Maryellen) (Entered: 07/03/2012)
2012-07-03
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding response to July 2, 2012 letters of Lupin and Amneal - re (62 in 1:11-cv-01106-LPS) Letter, (21 in 1:09-cv-00483-LPS, 29 in 1:10-cv-01112-LPS) Letter. (Noreika, Maryellen) (Entered: 07/03/2012)
2012-07-03
1
NOTICE OF APPEAL to the Federal Circuit of 278 Opinion, 304 Memorandum and Order, 311 Judgment . Appeal filed by Mylan Pharmaceuticals Inc.. (Horwitz, Richard) (Entered: 07/09/2012)
2012-07-09
1
APPEAL - Credit Card Payment of $ 455.00 received re 318 Notice of Appeal (Federal Circuit) filed by Mylan Pharmaceuticals Inc.. ( Filing fee $ 455, receipt number 0311-1102690.) (Horwitz, Richard)
2012-07-09
1
No Actions
Minute Entry for proceedings held before Judge Leonard P. Stark - Discovery Teleconference held on 7/10/2012. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:09-cv-00483-LPS, 1:10-cv-00892-LPS, 1:10-cv-01112-LPS, 1:11-cv-01106-LPS(ntl)
2012-07-10
1
No Actions
Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 318 Notice of Appeal (Federal Circuit). (els)
2012-07-11
1
No Actions
Notification regarding 318 Notice of Appeal (Federal Circuit) sent to Reporter Dibbs (els)
2012-07-11
1
No Actions
Notification regarding 318 Notice of Appeal (Federal Circuit) sent to Reporter Gaffigan (els)
2012-07-11
1
No Actions
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding Court's July 10, 2012 Oral Order. (Blumenfeld, Jack) (Entered: 07/13/2012)
2012-07-13
1
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding Court's July 10, 2012 Oral Order. (Blumenfeld, Jack) (Entered: 07/13/2012)
2012-07-13
1
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 318 Notice of Appeal (Federal Circuit) filed by Mylan Pharmaceuticals Inc. USCA Case Number 12-1523 (ntl) (Entered: 07/19/2012)
2012-07-19
1
NOTICE OF CROSS APPEAL to the Federal Circuit of 311 Judgment . Cross Appeal filed by Galderma Laboratories Inc., Galderma Laboratories LP. (Blumenfeld, Jack) (Entered: 07/20/2012)
2012-07-20
1
NOTICE OF CROSS APPEAL to the Federal Circuit of 311 Judgment . Cross Appeal filed by New York University. (Blumenfeld, Jack) (Entered: 07/20/2012)
2012-07-20
1
TRANSCRIPT REQUEST by Galderma Laboratories Inc., Galderma Laboratories LP, New York University TRANSCRIPT NOT NEEDED (Blumenfeld, Jack) (Entered: 07/20/2012)
2012-07-20
1
APPEAL - Credit Card Payment of $ 455.00 received re 321 Notice of Cross Appeal filed by Galderma Laboratories LP, Galderma Laboratories Inc., 322 Notice of Cross Appeal filed by New York University. ( Filing fee $ 455, receipt number 0311-1109746.) (Blumenfeld, Jack)
2012-07-20
1
No Actions
TRANSCRIPT REQUEST by Mylan Pharmaceuticals Inc. Already on file (Moore, David) (Entered: 07/23/2012)
2012-07-23
1
ORAL ORDER re ( 180 in 1:10-cv-00892-LPS, 309 in 1:09-cv-00184-LPS) MOTION for Release of Bond Obligation filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc. is DENIED. ORDERED by Judge Leonard P. Stark on 7/24/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 07/24/2012)
2012-07-24
1
APPEAL - Credit Card Payment of $ 455.00 received re 322 Notice of Cross Appeal filed by New York University. ( Filing fee $ 455, receipt number 0311-1110825.) (Blumenfeld, Jack)
2012-07-24
1
No Actions
Cross Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 321 Notice of Cross Appeal. (els)
2012-07-24
1
No Actions
Notification regarding 321 Notice of Cross Appeal sent to Reporter Dibbs (els)
2012-07-24
1
No Actions
Notification regarding 321 Notice of Cross Appeal sent to Reporter Gaffigan (els)
2012-07-24
1
No Actions
Cross Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 322 Notice of Cross Appeal. (els)
2012-07-24
1
No Actions
Notification regarding 322 Notice of Cross Appeal sent to Reporter Dibbs (els)
2012-07-24
1
No Actions
Notification regarding 322 Notice of Cross Appeal sent to Reporter Gaffigan (els)
2012-07-24
1
No Actions
AMENDED ORAL ORDER: Having reviewed the papers submitted (C.A. No. 09-184 D.I. 309, 312, 313; C.A. No. 10-892 D.I. 180, 183, 184), IT IS HEREBY ORDERED that Galderma's Motion to Release Bond (C.A. No. 09-184 D.I. 309; C.A. No. 10-892 D.I. 180) is DENIED. Mylan has filed a Notice of Appeal. (C.A. No. 09-184 D.I. 318; C.A. No. 10-892 D.I. 187) Issues that may be addressed on appeal include issues relating to whether Mylan is entitled to compensation from the bond. Accordingly, the Court sees no just reason to permit Galderma to release the bond at this time. ORDERED by Judge Leonard P. Stark on 7/26/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 07/26/2012)
2012-07-26
1
Official Transcript of Telephone Conference held on July 10, 2012 before Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/22/2012. Redacted Transcript Deadline set for 9/4/2012. Release of Transcript Restriction set for 10/30/2012. (bpg) (Entered: 08/01/2012)
2012-08-01
1
Amended NOTICE OF APPEAL to the Federal Circuit of 304 Memorandum and Order, 311 Judgment . Appeal filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 08/03/2012)
2012-08-03
1
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 322 Notice of Cross Appeal filed by New York University. USCA Case Number 12-1556. (ntl) (Entered: 08/06/2012)
2012-08-03
1
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 321 Notice of Cross Appeal filed by Galderma Laboratories LP, Galderma Laboratories Inc. USCA Case Number 12-1557. (ntl) (Entered: 08/06/2012)
2012-08-03
1
Amended Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 328 Notice of Appeal (Federal Circuit). (els)
2012-08-06
1
No Actions
Notification regarding Notice of Appeal and Docket Sheet to USCA sent to Reporter Dibbs (els)
2012-08-06
1
No Actions
Notification regarding Notice of Appeal and Docket Sheet to USCA sent to Reporter Gaffigan (els)
2012-08-06
1
No Actions
MOTION for Release of Bond Obligation - filed by Galderma Laboratories Inc., Galderma Laboratories LP. (Blumenfeld, Jack) Modified on 8/29/2013 (ntl). (Entered: 08/28/2013)
2013-08-28
1
MANDATE of USCA as to 328 Notice of Appeal (Federal Circuit) filed by Mylan Pharmaceuticals Inc., 318 Notice of Appeal (Federal Circuit) filed by Mylan Pharmaceuticals Inc., 321 Notice of Cross Appeal filed by Galderma Laboratories LP, Galderma Laboratories Inc., 322 Notice of Cross Appeal filed by New York University. USCA Decision: Affirmed in part, Vacated in part, and Remanded. (ntl) (Entered: 09/13/2013)
2013-09-13
1
ORAL ORDER: IT IS HEREBY ORDERED that the parties shall submit a status report on or before 9/30/13. ORDERED by Judge Leonard P. Stark on 9/16/13. Associated Cases: 1:09-cv-00184-LPS et al.(ntl) (Entered: 09/16/2013)
2013-09-16
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding status. (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 09/30/2013)
2013-09-30
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding status. (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 09/30/2013)
2013-09-30
1
ORAL ORDER: Having reviewed the parties' joint status report (D.I. 334), IT IS HEREBY ORDERED that: (1) the parties shall file a further joint status report no later than October 30, 2013; and (2) Plaintiffs' unopposed motion for release of bond obligation (D.I. 331 ) is GRANTED. ORDERED by Judge Leonard P. Stark on 10/1/13. (ntl) (Entered: 10/01/2013)
2013-10-01
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding Joint Status Report. (Noreika, Maryellen) (Entered: 10/30/2013)
2013-10-30
1
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding Joint Status Report. (Noreika, Maryellen) (Entered: 10/30/2013)
2013-10-30
1
STIPULATION of Dismissal of Invalidity Defenses and Counterclaims for Claims 2 and 14 of U.S. Patent No. 5,789,395 and Claim 2 of U.S. Patent No. 5,919,775-- by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York. (Blumenfeld, Jack) (Entered: 11/26/2013)
2013-11-26
1
ORDER re 337 Stipulation of Dismissal filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc., Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 12/3/13. (ntl) (Entered: 12/03/2013)
2013-12-03
1
ORDER AND NOTICE REGARDING RETURN OF SEALED DOCUMENTS: Pursuant to the attached STANDING ORDER dated January 8, 2013, sealed documents identified on the highlighted docket sheet will be claimed by the FILING party/attorney no later than 3/14/14. Filing attorney or their designee shall CLAIM their sealed documents by sending an E-MAIL, Subject: Return of Sealed Documents, to returnsealeddocs@ded.uscourts.gov, listing the case number and a contact's name, phone number and address. Parties not registered in CM/ECF may call our Help Desk at 302-573-6170 to claim their sealed documents. Once sealed documents are claimed, THE CLERK SHALL prepare receipts and contact filers WHEN THEIR DOCUMENTS ARE READY FOR PICK-UP at the Clerk's Office, 844 N. King Street, Intake Help Desk, Room 4209. Documents not claimed shall be unsealed and handled pursuant to the standing order. (Attachments: # 1 Highlighted Docket Sheet) (cla, ) (Entered: 02/28/2014)
2014-02-28
1
ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Morris, Nichols, Arsht & Tunnell : D.I. # 88, 89, 90, 91, 138, 139, 140, 197, 209, 210, 212, 258, 284, 287, 288 (cla, ) (Entered: 03/04/2014)
2014-02-28
1
ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Potter Anderson & Corroon : D.I. # 105, 106, 108, 109, 110, 111, 112, 113, 114, 161, 164, 168, 200, 201, 202, 203, 211, 213, 218, 280, 281, 282, 286, 300 (cla, ) (Entered: 03/14/2014)
2014-03-14
1
Letter
2024-03-26
1
Letter
2025-04-28
1
Remark
2025-04-28
1
No Actions